{"protocolSection":{"identificationModule":{"nctId":"NCT05073003","orgStudyIdInfo":{"id":"212149"},"secondaryIdInfos":[{"id":"2021-000891-12","type":"EUDRACT_NUMBER"}],"organization":{"fullName":"GlaxoSmithKline","class":"INDUSTRY"},"briefTitle":"A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants","officialTitle":"A Staged Phase I/II Observer-blind, Randomised, Controlled, Multi-country Study to Evaluate the Safety, Reactogenicity, and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against S. Sonnei and S. Flexneri, Serotypes 1b, 2a, and 3a, in Adults in Europe (Stage 1) Followed by Age De-escalation From Adults to Children and Infants, and Dose-finding in Infants in Africa (Stage 2)"},"statusModule":{"statusVerifiedDate":"2026-06","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-10-06","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-06-24","type":"ACTUAL"},"completionDateStruct":{"date":"2025-06-24","type":"ACTUAL"},"studyFirstSubmitDate":"2021-09-29","studyFirstSubmitQcDate":"2021-09-29","studyFirstPostDateStruct":{"date":"2021-10-11","type":"ACTUAL"},"resultsFirstSubmitDate":"2025-12-22","resultsFirstSubmitQcDate":"2026-06-18","resultsFirstPostDateStruct":{"date":"2026-06-22","type":"ACTUAL"},"lastUpdateSubmitDate":"2026-06-18","lastUpdatePostDateStruct":{"date":"2026-06-22","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"GlaxoSmithKline","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false,"isUsExport":false},"descriptionModule":{"briefSummary":"The aim of the current clinical study was to evaluate, for the first time in humans (FTIH), the safety and immunogenicity of the altSonflex1-2-3 candidate vaccine against S. sonnei and S. flexneri serotypes 1b, 2a, and 3a. The vaccine was first administered to adults 18 to 50 years of age in Europe. Subsequently, the vaccine was administered to a shigellosis-endemic population in Africa, first to adults 18 to 50 years of age, then to children 24 to 59 months of age, and finally to infants 9 months of age. Infants also received a third vaccination. Three different doses of the vaccine \\[low, medium, and high amounts of antigen\\] were evaluated using an age de-escalation approach (from the least vulnerable adult population to the most vulnerable paediatric population). The results of this study allowed the selection of the most appropriate dose for further vaccine development in infants 9 months of age, which was the main target age group for this vaccine."},"conditionsModule":{"conditions":["Diarrhoea"],"keywords":["Shigella infection","Shigellosis","Diarrhoea","S. sonnei","S. flexneri","Low and middle income countries"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1","PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"SEQUENTIAL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"QUADRUPLE","maskingDescription":"Observer blind","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":551,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","type":"EXPERIMENTAL","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) of O-antigen (OAg) each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 High Dose"]},{"label":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","type":"EXPERIMENTAL","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 High Dose"]},{"label":"Stage 1 Adults: Placebo Group","type":"PLACEBO_COMPARATOR","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan.","interventionNames":["Drug: altSonflex Placebo"]},{"label":"Stage 2 Adults: altSonflex1-2-3 High Dose","type":"EXPERIMENTAL","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 High Dose"]},{"label":"Stage 2 Adults: Control","type":"ACTIVE_COMPARATOR","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85.","interventionNames":["Biological: Menveo","Combination Product: Boostrix"]},{"label":"Stage 2 Children: altSonflex1-2-3 Medium Dose","type":"EXPERIMENTAL","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 Medium Dose"]},{"label":"Stage 2 Children: altSonflex1-2-3 High Dose","type":"EXPERIMENTAL","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 High Dose"]},{"label":"Stage 2 Children: Control","type":"ACTIVE_COMPARATOR","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85.","interventionNames":["Biological: Menveo","Combination Product: Typhim-Vi"]},{"label":"Stage 2 Infants safety cohort: altSonflex1-2-3 Low Dose","type":"EXPERIMENTAL","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 Low Dose","Biological: MR-Vac"]},{"label":"Stage 2 Infants safety cohort: altSonflex1-2-3 Medium Dose","type":"EXPERIMENTAL","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 Medium Dose","Biological: MR-Vac"]},{"label":"Stage 2 Infants safety cohort: altSonflex1-2-3 High Dose","type":"EXPERIMENTAL","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 High Dose","Biological: MR-Vac"]},{"label":"Stage 2 Infants safety cohort: Control","type":"ACTIVE_COMPARATOR","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281.","interventionNames":["Biological: Menveo","Combination Product: INFANRIX HEXA","Biological: MR-Vac"]},{"label":"Stage 2 Infants dose-finding cohort: altSonflex1-2-3 Low Dose","type":"EXPERIMENTAL","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 Low Dose","Biological: MR-Vac"]},{"label":"Stage 2 Infants dose-finding cohort: altSonflex1-2-3 Medium Dose","type":"EXPERIMENTAL","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 Medium Dose","Biological: MR-Vac"]},{"label":"Stage 2 Infants dose-finding cohort: altSonflex1-2-3 High Dose","type":"EXPERIMENTAL","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","interventionNames":["Biological: AltSonflex1-2-3 High Dose","Biological: MR-Vac"]},{"label":"Stage 2 Infants dose-finding cohort: Control","type":"ACTIVE_COMPARATOR","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses.","interventionNames":["Biological: Menveo","Combination Product: INFANRIX HEXA","Biological: MR-Vac"]}],"interventions":[{"type":"BIOLOGICAL","name":"AltSonflex1-2-3 High Dose","description":"2 doses in adults 18-50 years of age and children 24-59 months of age, 3 doses in infants 9 months of age","armGroupLabels":["Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","Stage 2 Adults: altSonflex1-2-3 High Dose","Stage 2 Children: altSonflex1-2-3 High Dose","Stage 2 Infants dose-finding cohort: altSonflex1-2-3 High Dose","Stage 2 Infants safety cohort: altSonflex1-2-3 High Dose"]},{"type":"BIOLOGICAL","name":"AltSonflex1-2-3 Medium Dose","description":"2 doses in children 24-59 months of age, 3 doses in infants 9 months of age","armGroupLabels":["Stage 2 Children: altSonflex1-2-3 Medium Dose","Stage 2 Infants dose-finding cohort: altSonflex1-2-3 Medium Dose","Stage 2 Infants safety cohort: altSonflex1-2-3 Medium Dose"]},{"type":"BIOLOGICAL","name":"AltSonflex1-2-3 Low Dose","description":"3 doses in infants 9 months of age","armGroupLabels":["Stage 2 Infants dose-finding cohort: altSonflex1-2-3 Low Dose","Stage 2 Infants safety cohort: altSonflex1-2-3 Low Dose"]},{"type":"BIOLOGICAL","name":"Menveo","description":"1 dose in adults 18-50 years of age (stage 2) and children 24-59 months of age and 2 doses in infants 9 months of age","armGroupLabels":["Stage 2 Adults: Control","Stage 2 Children: Control","Stage 2 Infants dose-finding cohort: Control","Stage 2 Infants safety cohort: Control"]},{"type":"COMBINATION_PRODUCT","name":"Boostrix","description":"1 dose in adults 18-50 years of age (stage 2)","armGroupLabels":["Stage 2 Adults: Control"]},{"type":"COMBINATION_PRODUCT","name":"INFANRIX HEXA","description":"1 dose in infants 9 months of age","armGroupLabels":["Stage 2 Infants dose-finding cohort: Control","Stage 2 Infants safety cohort: Control"]},{"type":"COMBINATION_PRODUCT","name":"Typhim-Vi","description":"1 dose in children 24-59 months of age","armGroupLabels":["Stage 2 Children: Control"]},{"type":"BIOLOGICAL","name":"MR-Vac","description":"2 doses in children 24-59 months of age","armGroupLabels":["Stage 2 Infants dose-finding cohort: Control","Stage 2 Infants dose-finding cohort: altSonflex1-2-3 High Dose","Stage 2 Infants dose-finding cohort: altSonflex1-2-3 Low Dose","Stage 2 Infants dose-finding cohort: altSonflex1-2-3 Medium Dose","Stage 2 Infants safety cohort: Control","Stage 2 Infants safety cohort: altSonflex1-2-3 High Dose","Stage 2 Infants safety cohort: altSonflex1-2-3 Low Dose","Stage 2 Infants safety cohort: altSonflex1-2-3 Medium Dose"]},{"type":"DRUG","name":"altSonflex Placebo","description":"2 doses in adults 18-50 years of age (stage 1)","armGroupLabels":["Stage 1 Adults: Placebo Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Stage 2: Geometric Mean Concentrations (GMCs) of Anti-serotype Specific Shigella Lipopolysaccharide (LPS)/O-Antigen (OAg) Serum Immunoglobulin G (IgG) in Participants 9 Months of Age in Africa","description":"Anti-serotype specific Shigella LPS/OAg serum IgG GMCs were measured by enzyme-linked immunosorbent assay (ELISA) and expressed in ELISA units per milliliter (EU/mL) of serum. Four serotypes were tested. Due to the fact, that the Per protocol set (PPS) for Stage 2 Infants - dose finding cohort had less than the 72 participants per group defined in the protocol as a minimum number of participants to ensure power of the analysis, the Stage 2 Infants Safety cohort and Dose-finding cohort were pooled for the statistical analysis as per the Statistical Analysis Plan. As per protocol, statistical analysis was performed only for the S. sonnei serotype, comparing Stage 2 Infants: Pooled groups (medium vs low dose); and Stage 2 Infants Dose-finding groups (high vs low dose). The objective of this outcome measure is to identify the preferred dose of each component of the altSonflex1-2-3 vaccine for infants 9 months of age in Africa, therefore control groups were not analyzed.","timeFrame":"At Day 281 (28 days after the third study intervention)"},{"measure":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Solicited Administration Site Events","description":"The solicited administration site events assessed were erythema, pain, and swelling.","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 169 [depending on the vaccination schedule])"},{"measure":"Stage 1: Number of Adults 18 to 50 Years of Age in Europe With Solicited Systemic Events","description":"The solicited systemic event assessed was fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 169 [depending on the vaccination schedule])"},{"measure":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Unsolicited Adverse Events (AEs)","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","timeFrame":"Within 28 days after each study intervention (administered at at Day 1, Day 85 and Day 169 [depending on the vaccination schedule])"},{"measure":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Serious Adverse Events (SAEs)","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","timeFrame":"From Day 1 to Day 113 and/or Day 197"},{"measure":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention","description":"Panel tests include measures of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and white blood cells (WBC). Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 8"},{"measure":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 85/Day 169 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 92 (Stage 1 Adults: altSonflex1-2-3 High Dose Group 1), at Day 176 (Stage 1 Adults: altSonflex1-2-3 High Dose Group 2) and at Day 92/Day 176 (Stage 1 Adults: Placebo Group)"},{"measure":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Solicited Administration Site Events","description":"The solicited administration site events assessed were pain, erythema, and swelling.","timeFrame":"Within 7 days after each study intervention (administered at Day 1 and Day 85)"},{"measure":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Solicited Systemic Events","description":"The solicited systemic event assessed was fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","timeFrame":"Within 7 days after each study intervention (administered at Day 1 and Day 85)"},{"measure":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Unsolicited Adverse Events (AEs)","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","timeFrame":"Within 28 days after each study intervention (administered at Day 1 and Day 85)"},{"measure":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Serious Adverse Events (SAEs)","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","timeFrame":"From Day 1 to Day 113"},{"measure":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 8"},{"measure":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 85 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 92"},{"measure":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Solicited Administration Site Events","description":"The solicited administration site events assessed were erythema, pain, and swelling.","timeFrame":"Within 7 days after each study intervention (administered at Day 1 and Day 85)"},{"measure":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Solicited Systemic Events","description":"The solicited systemic event assessed was fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","timeFrame":"Within 7 days after each study intervention (administered at Day 1 and Day 85)"},{"measure":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Unsolicited Adverse Events (AEs)","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","timeFrame":"Within 28 days after each study intervention (administered at Day 1 and Day 85)"},{"measure":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Serious Adverse Events (SAEs)","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","timeFrame":"From Day 1 to Day 113"},{"measure":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 8"},{"measure":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 85 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 92"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Solicited Administration Site Events - Infants Safety Cohort","description":"The solicited administration site events assessed were erythema, pain, and swelling.","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 253)"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Solicited Administration Site Events - Infants Dose-finding Cohort","description":"The solicited administration site events assessed were erythema, pain, and swelling.","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 253)"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Solicited Systemic Events - Infants Safety Cohort","description":"The solicited systemic event is fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 253)"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Solicited Systemic Events - Infants Dose-finding Cohort","description":"The solicited systemic event is fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 253)"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Unsolicited Adverse Events (AEs) - Infants Safety Cohort","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","timeFrame":"Within 28 days after each study intervention (administered at Day 1, Day 85 and Day 253)"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Unsolicited Adverse Events (AEs) - Infants Dose-finding Cohort","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","timeFrame":"Within 28 days after each study intervention (administered at Day 1, Day 85 and Day 253)"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Serious Adverse Events (SAEs) - Infants Safety Cohort","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","timeFrame":"From Day 1 to Day 281"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Serious Adverse Events (SAEs) - Infants Dose-finding Cohort","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","timeFrame":"From Day 1 to Day 281"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention - Infants Safety Cohort","description":"Panel tests include measures of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, potassium, sodium, urea, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and white blood cells (WBC). Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 8"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention - Infants Dose-finding Cohort","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 8"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention - Infants Safety Cohort","description":"Panel tests include measures of ALT, AST, creatinine, potassium, sodium, urea, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 92"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention - Infants Dose-finding Cohort","description":"Panel tests include measures of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, potassium, sodium, urea, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and white blood cells (WBC). Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 92"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Third Study Intervention - Infants Safety Cohort","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 260"},{"measure":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Third Study Intervention - Infants Dose-finding Cohort","description":"Panel tests include measures of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, potassium, sodium, urea, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and white blood cells (WBC). Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","timeFrame":"At Day 260"}],"secondaryOutcomes":[{"measure":"Stage 1: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 18 to 50 Years of Age in Europe","description":"Anti-serotype specific Shigella LPS/OAg serum IgG GMCs were measured by ELISA and expressed in EU/mL of serum. S. sonnei, S. flexneri 1b, S. flexneri 2a, and S. flexneri 3a serotypes were tested.","timeFrame":"At Day 1 and Day 85/Day 169(before each study intervention); at Day 15 (14 days after the first study intervention); at Day 29 and Day 113/Day 197 (28 days after each study intervention)"},{"measure":"Stage 2: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 18 to 50 Years of Age in Africa","timeFrame":"At Day 1 and Day 85 (before each study intervention administration) and Day 29 and Day 113 (28 days after each study intervention administration)"},{"measure":"Stage 2: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 24 to 59 Months of Age in Africa","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)"},{"measure":"Stage 2: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 9 Months of Age in Africa - Infants Safety Cohort","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention administration) and Day 29, Day 113 and Day 281 (28 days after each study intervention administration)"},{"measure":"Stage 2: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 9 Months of Age in Africa - Dose-finding Cohort","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention administration) and Day 29, Day 113 and Day 281 (28 days after each study intervention administration)"},{"measure":"Stage 1: Number of Participants 18 to 50 Years of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/OAg","timeFrame":"At Day 1 and Day 85/Day 169 (before each study intervention); at Day 15 (14 days after the first study intervention); at Day 29 and Day 113/Day 197 (28 days after each study intervention)"},{"measure":"Stage 2: Number of Participants 18 to 50 Years of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/OAg","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)"},{"measure":"Stage 2: Number of Participants 24 to 59 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/OAg","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)"},{"measure":"Stage 2: Number of Participants 9 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/Oag - Safety Cohort","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention) and Day 29, Day 113 and Day 281 (28 days after each study intervention)"},{"measure":"Stage 2: Number of Participants 9 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/Oag - Dose-finding Cohort","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention) and Day 29, Day 113 and Day 281 (28 days after each study intervention)"},{"measure":"Stage 1: Number of Participants 18 to 50 Years of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg","timeFrame":"At Day 1 and Day 85/Day 169 (before each study intervention); at Day 15 (14 days after the first study intervention); at Day 29 and Day 113/Day 197 (28 days after each study intervention)"},{"measure":"Stage 2: Number of Participants 18 to 50 Years of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)"},{"measure":"Stage 2: Number of Participants 24 to 59 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)"},{"measure":"Stage 2: Number of Participants 9 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg - Safety Cohort","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention) and Day 29, Day 113 and Day 281 (28 days after each study intervention)"},{"measure":"Stage 2: Number of Participants 9 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg - Dose-finding Cohort","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention) and Day 29, Day 113 and Day 281 (28 days after each study intervention)"},{"measure":"Stage 1: Number of Participants 18 to 50 Years of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA","timeFrame":"At Day 15 (14 days after the first study intervention) and at Day 29 and Day 113/Day 197 (28 days after each study intervention) compared to baseline (Day 1 and Day 85/Day 169)"},{"measure":"Stage 2: Number of Participants 18 to 50 Years of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA","timeFrame":"At Day 29 and Day 113 (28 days after each study intervention) compared to baseline (Day 1 and Day 85)"},{"measure":"Stage 2: Number of Participants 24 to 59 Months of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA","timeFrame":"At Day 29 and Day 113 (28 days after each study intervention) compared to baseline (Day 1 and Day 85)"},{"measure":"Stage 2: Number of Participants 9 Months of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA - Safety Cohort","timeFrame":"At Day 29, Day 113 and Day 281 (28 days after each study intervention) compared to baseline (Day 1, Day 85 and Day 253)"},{"measure":"Stage 2: Number of Participants 9 Months of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA - Dose-finding Cohort","timeFrame":"At Day 29, Day 113 and Day 281 (28 days after each study intervention) compared to baseline (Day 1, Day 85 and Day 253)"},{"measure":"Stage 2: Anti-measles IgG Concentrations in Participants 9 Months of Age in the Dose-finding Cohort","timeFrame":"At Day 1 (before first measles and rubella vaccine (MR-VAC)) and at Day 281 (28 days after the second MR-VAC administration)"},{"measure":"Stage 2: Anti-rubella IgG Concentrations in Participants 9 Months of Age in the Dose-finding Groups","timeFrame":"At Day 1 (before first measles and rubella vaccine (MR-VAC)) and at Day 281 (28 days after the second MR-VAC administration)"},{"measure":"Stage 2: Number of Participants 9 Months of Age in the Dose-finding Groups Achieving Anti-measles IgG Concentrations of ≥150 Milli International Units Per Milliliter (mIU/mL) and ≥200 mIU/mL","timeFrame":"Day 281 (28 days after the second MR-VAC administration)"},{"measure":"Stage 2: Number of Participants 9 Months of Age in the Dose-finding Groups Achieving Anti-rubella IgG Concentrations of ≥4 mIU/mL and ≥10 mIU/mL","timeFrame":"Day 281 (28 days after the second MR-VAC administration)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nAll participants:\n\n• Participants and/or participants' parent(s)/legally acceptable representative(s) (LARs), who, in the opinion of the investigator, could and would comply with the requirements of the protocol (e.g. completion of the diary cards, return for follow-up visits).\n\n* Written or witnessed/thumb-printed informed consent was obtained from the participant/parent(s)/LAR(s) of the participant prior to the performance of any study-specific procedure.\n* Healthy participants, as established by medical history, clinical examination, and laboratory assessment.\n* Participants who satisfied all screening requirements.\n* Participants who were seronegative for hepatitis B and hepatitis C.\n* Participants who were negative for human leukocyte antigen B27 (HLA-B27).\n\nAdults 18 to 50 years of age:\n\n* A male or female between, and including, 18 and 50 years of age at the time of the first study intervention administration.\n* Female participants of non-childbearing potential may be enrolled in the study. Non-childbearing potential is defined as pre-menarche, current bilateral tubal ligation or occlusion, hysterectomy, bilateral ovariectomy or post-menopause.\n* Female participants of childbearing potential may be enrolled in the study, if the participant:\n\n  \\- has practiced adequate contraception for 1 month prior to study intervention administration, and\n\n  \\- has a negative pregnancy test on the day of study intervention administration, and\n  * has agreed to continue adequate contraception during the entire treatment period and for 1 month after completion of the study intervention administration series.\n* Participants seronegative for human immunodeficiency virus (HIV).\n\nChildren 24 to 59 months of age:\n\n* A male or female between, and including, 24 and 59 months of age at the time of first vaccination.\n* A normal nutritional Z score (-2 standard deviations or greater).\n* Participants who had previously completed routine childhood vaccinations to the best knowledge of the participant's parent(s)/LAR(s).\n* Participants who were born after a gestation period of ≥37 weeks.\n* Participants who were seronegative for HIV.\n\nInfants 9 months of age:\n\n* A male or female 9 months of age at the time of first vaccination.\n* A normal nutritional Z score (-2 standard deviations or greater).\n* Participants who had previously completed routine childhood vaccinations to the best knowledge of the participant's parent(s)/LAR(s).\n* Participants who were born after a gestation period of \\>=37 weeks.\n* Participants who were negative for HIV, as confirmed by deoxyribonucleic acid (DNA) polymerase chain reaction (PCR) testing.\n\nExclusion Criteria:\n\nAll participants:\n\n• Known exposure to Shigella during the lifetime of the participant, as confirmed during interview with the participant or documented by patient records (e.g., history of microbiologically confirmed Shigella infection), recent travel\\* (within 2 years) to a country where Shigella or other enteric infections are endemic, or recent occupation\\* (within 3 years) involving Shigella species.\n\nExclusion due to travel or occupation was applicable only to adults 18 to 50 years of age in Europe (Stage 1).\n\n* Progressive, unstable, or uncontrolled clinical conditions.\n* A history (known or suspected) of any reaction or hypersensitivity likely to be exacerbated by any component of the study vaccine.\n* Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination (no laboratory testing was required).\n* Hypersensitivity, including allergy, to medicinal products or medical equipment whose use was foreseen in this study.\n* Clinical conditions representing a contraindication to IM vaccination and blood draws.\n* Any behavioural or cognitive impairment or psychiatric disease that, in the opinion of the investigator, might have interfered with the participant's ability to participate in the study.\n* Acute disease and/or fever (defined as temperature ≥38.0°C) at the time of enrolment\\*.\n\nThe participant could still be enrolled into the study at a time when the acute disease and/or fever had resolved.\n\n* Any clinically significant haematological and/or biochemical laboratory abnormality.\n* A confirmed positive COVID-19 test during the period starting 30 days before the first administration of study vaccines (Day -30 to Day 1).\n* Any other clinical condition that, in the opinion of the investigator, might have posed additional risk to the participant due to participation in the study.\n* Administration of long-acting immune-modifying drugs at any time during the study period (e.g. infliximab).\n* Prior receipt of an experimental Shigella vaccine or live Shigella challenge.\n* Use of any investigational or non-registered product (drug, vaccine, or medical device)\\* other than the study vaccine during the period starting 30 days before the first dose of study intervention (Day -30 to Day 1), or planned use during the study period.\n\nUse of herbs and traditional treatments was not considered an exclusion criterion.\n\n• Administration of a vaccine not foreseen\\* by the Study Protocol during the period starting at -21 days before the first dose (-28 days in the case of live vaccines) and ending after the last dose of study intervention administration\\*\\*.\n\nVaccines allowed by the Protocol included flu and COVID-19 vaccines in all participants and EPI vaccines in children and infants.\n\n\\*In case of emergency mass vaccination, the time period above could be reduced.\n\n* Concurrent participation in another clinical study, at any time during the study period, in which the participant had been or would be exposed to an investigational or non-investigational intervention (drug or invasive medical device).\n* Any study personnel or immediate dependents, family, or household members.\n\nAdults 18 to 50 years of age:\n\n* Acute or chronic illness, clinically significant pulmonary, cardiovascular, hepatic, or renal functional abnormality, as determined by physical examination or laboratory screening tests.\n* Chronic administration (defined as more than 14 days in total) of immunosuppressants or other immune-modifying drugs during the period starting 3 months prior to the first vaccine study intervention. For corticosteroids, this meant a prednisone equivalent ≥20 mg/day for adult participants. Inhaled and topical steroids were allowed.\n* Pregnant or lactating females.\n* Females planning to become pregnant or planning to discontinue contraceptive precautions.\n* A history of or current chronic alcohol consumption and/or drug abuse.\n\nAdults 18 to 50 years of age and children 24 to 59 months of age:\n\n• Administration of immunoglobulins and/or any blood products or plasma derivatives, or bone marrow transplantation, during the period starting 3 months before the first dose of study vaccine or planned administration during the study period.\n\nChildren 24 to 59 months of age and infants 9 months of age:\n\n* Acute or chronic clinically significant pulmonary, cardiovascular, hepatic, or renal functional abnormality, as determined by physical examination or laboratory screening tests.\n* Chronic administration (defined as more than 14 days in total) of immunosuppressants or other immune-modifying drugs during the period starting 3 months prior to the first vaccine dose. For corticosteroids, this meant prednisone ≥0.5 mg/kg/day or 20 mg/day, whichever was the maximum dose for paediatric participants. Inhaled and topical steroids were allowed.\n* A child in care.\n\nInfants 9 months of age:\n\n• Administration of immunoglobulins and/or any blood products or plasma derivatives, or bone marrow transplantation, from birth or planned administration during the study period.","healthyVolunteers":true,"sex":"ALL","minimumAge":"9 Months","maximumAge":"50 Years","stdAges":["CHILD","ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"GSK Clinical Trials","affiliation":"GlaxoSmithKline","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"GSK Investigational Site","city":"Ghent","zip":"9000","country":"Belgium","geoPoint":{"lat":51.05,"lon":3.71667}},{"facility":"GSK Investigational Site","city":"Kericho","zip":"20200","country":"Kenya","geoPoint":{"lat":-0.36774,"lon":35.28314}}]},"referencesModule":{"references":[{"pmid":"38853614","type":"DERIVED","citation":"Leroux-Roels I, Maes C, Mancini F, Jacobs B, Sarakinou E, Alhatemi A, Joye J, Grappi S, Cilio GL, Serry-Bangura A, Vitali CG, Ferruzzi P, Marchetti E, Necchi F, Rappuoli R, De Ryck I, Auerbach J, Colucci AM, Rossi O, Conti V, Scorza FB, Arora AK, Micoli F, Podda A, Nakakana UN; Shigella Project Team. Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study. J Infect Dis. 2024 Oct 16;230(4):e971-e984. doi: 10.1093/infdis/jiae273."}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"GSK will assess requests from qualified researchers for anonymized individual patient-level data and related study documents. Data sharing is subject to certain criteria, conditions, and exceptions. For further information, refer to https://www.gsk-studyregister.com/About\\_GSK\\_Patient\\_Level\\_Data\\_Sharing\\_Final\\_13July2023.pdf.","infoTypes":["STUDY_PROTOCOL","SAP","ICF","CSR"],"timeFrame":"IPD will be made available within 6 months of publishing the results of the primary endpoints, key secondary endpoints and safety data of the study.","accessCriteria":"Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension can be granted, when justified, for up to another 12 months.","url":"https://www.gsk-studyregister.com/About_GSK_Patient_Level_Data_Sharing_Final_13July2023.pdf"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"As pre-specified in the Statistical Analysis Plan (SAP), the participants that received placebo in Stage 1 were pooled for all analyses (demography, immunogenicity and safety).","recruitmentDetails":"Out of 551 participants enrolled, 550 started the study and were included in the Exposed set.","groups":[{"id":"FG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."},{"id":"FG003","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG004","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."},{"id":"FG005","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG006","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG007","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."},{"id":"FG008","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG009","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG010","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG011","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."},{"id":"FG012","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG013","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG014","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"FG015","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"34"},{"groupId":"FG001","numSubjects":"34"},{"groupId":"FG002","numSubjects":"34"},{"groupId":"FG003","numSubjects":"10"},{"groupId":"FG004","numSubjects":"10"},{"groupId":"FG005","numSubjects":"10"},{"groupId":"FG006","numSubjects":"10"},{"groupId":"FG007","numSubjects":"20"},{"groupId":"FG008","numSubjects":"10"},{"groupId":"FG009","numSubjects":"10"},{"groupId":"FG010","numSubjects":"10"},{"groupId":"FG011","numSubjects":"30"},{"groupId":"FG012","numSubjects":"82"},{"groupId":"FG013","numSubjects":"81"},{"groupId":"FG014","numSubjects":"83"},{"groupId":"FG015","numSubjects":"82"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"29"},{"groupId":"FG001","numSubjects":"34"},{"groupId":"FG002","numSubjects":"28"},{"groupId":"FG003","numSubjects":"10"},{"groupId":"FG004","numSubjects":"10"},{"groupId":"FG005","numSubjects":"10"},{"groupId":"FG006","numSubjects":"10"},{"groupId":"FG007","numSubjects":"20"},{"groupId":"FG008","numSubjects":"9"},{"groupId":"FG009","numSubjects":"8"},{"groupId":"FG010","numSubjects":"10"},{"groupId":"FG011","numSubjects":"27"},{"groupId":"FG012","numSubjects":"69"},{"groupId":"FG013","numSubjects":"71"},{"groupId":"FG014","numSubjects":"73"},{"groupId":"FG015","numSubjects":"71"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"6"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"1"},{"groupId":"FG009","numSubjects":"2"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"3"},{"groupId":"FG012","numSubjects":"13"},{"groupId":"FG013","numSubjects":"10"},{"groupId":"FG014","numSubjects":"10"},{"groupId":"FG015","numSubjects":"11"}]}],"dropWithdraws":[{"type":"Adverse Events (including death)","reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"},{"groupId":"FG012","numSubjects":"0"},{"groupId":"FG013","numSubjects":"1"},{"groupId":"FG014","numSubjects":"0"},{"groupId":"FG015","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"},{"groupId":"FG012","numSubjects":"1"},{"groupId":"FG013","numSubjects":"3"},{"groupId":"FG014","numSubjects":"2"},{"groupId":"FG015","numSubjects":"5"}]},{"type":"Consent withdrawal, not due to a (Serious) Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"1"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"2"},{"groupId":"FG012","numSubjects":"9"},{"groupId":"FG013","numSubjects":"4"},{"groupId":"FG014","numSubjects":"5"},{"groupId":"FG015","numSubjects":"5"}]},{"type":"Migrated / moved from the study area","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"1"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"1"},{"groupId":"FG012","numSubjects":"2"},{"groupId":"FG013","numSubjects":"2"},{"groupId":"FG014","numSubjects":"2"},{"groupId":"FG015","numSubjects":"0"}]},{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"4"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"1"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"},{"groupId":"FG012","numSubjects":"1"},{"groupId":"FG013","numSubjects":"0"},{"groupId":"FG014","numSubjects":"1"},{"groupId":"FG015","numSubjects":"1"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."},{"id":"BG003","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG004","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."},{"id":"BG005","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG006","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG007","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."},{"id":"BG008","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG009","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG010","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG011","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."},{"id":"BG012","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG013","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG014","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"BG015","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."},{"id":"BG016","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"34"},{"groupId":"BG003","value":"10"},{"groupId":"BG004","value":"10"},{"groupId":"BG005","value":"10"},{"groupId":"BG006","value":"10"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"10"},{"groupId":"BG009","value":"10"},{"groupId":"BG010","value":"10"},{"groupId":"BG011","value":"30"},{"groupId":"BG012","value":"82"},{"groupId":"BG013","value":"81"},{"groupId":"BG014","value":"83"},{"groupId":"BG015","value":"82"},{"groupId":"BG016","value":"550"}]}],"measures":[{"title":"Age, Categorical","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"<=18 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"10"},{"groupId":"BG006","value":"10"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"10"},{"groupId":"BG009","value":"10"},{"groupId":"BG010","value":"10"},{"groupId":"BG011","value":"30"},{"groupId":"BG012","value":"82"},{"groupId":"BG013","value":"81"},{"groupId":"BG014","value":"83"},{"groupId":"BG015","value":"82"},{"groupId":"BG016","value":"428"}]},{"title":"Between 18 and 65 years","measurements":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"34"},{"groupId":"BG003","value":"10"},{"groupId":"BG004","value":"10"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"0"},{"groupId":"BG015","value":"0"},{"groupId":"BG016","value":"122"}]},{"title":">=65 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"0"},{"groupId":"BG015","value":"0"},{"groupId":"BG016","value":"0"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"27"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"6"},{"groupId":"BG005","value":"4"},{"groupId":"BG006","value":"4"},{"groupId":"BG007","value":"11"},{"groupId":"BG008","value":"7"},{"groupId":"BG009","value":"5"},{"groupId":"BG010","value":"4"},{"groupId":"BG011","value":"16"},{"groupId":"BG012","value":"32"},{"groupId":"BG013","value":"43"},{"groupId":"BG014","value":"41"},{"groupId":"BG015","value":"49"},{"groupId":"BG016","value":"310"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"4"},{"groupId":"BG005","value":"6"},{"groupId":"BG006","value":"6"},{"groupId":"BG007","value":"9"},{"groupId":"BG008","value":"3"},{"groupId":"BG009","value":"5"},{"groupId":"BG010","value":"6"},{"groupId":"BG011","value":"14"},{"groupId":"BG012","value":"50"},{"groupId":"BG013","value":"38"},{"groupId":"BG014","value":"42"},{"groupId":"BG015","value":"33"},{"groupId":"BG016","value":"240"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"BLACK OR AFRICAN AMERICAN","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"10"},{"groupId":"BG004","value":"10"},{"groupId":"BG005","value":"10"},{"groupId":"BG006","value":"10"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"10"},{"groupId":"BG009","value":"10"},{"groupId":"BG010","value":"10"},{"groupId":"BG011","value":"30"},{"groupId":"BG012","value":"82"},{"groupId":"BG013","value":"81"},{"groupId":"BG014","value":"83"},{"groupId":"BG015","value":"82"},{"groupId":"BG016","value":"448"}]}]},{"title":"WHITE","categories":[{"measurements":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"34"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"0"},{"groupId":"BG013","value":"0"},{"groupId":"BG014","value":"0"},{"groupId":"BG015","value":"0"},{"groupId":"BG016","value":"102"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Stage 2: Geometric Mean Concentrations (GMCs) of Anti-serotype Specific Shigella Lipopolysaccharide (LPS)/O-Antigen (OAg) Serum Immunoglobulin G (IgG) in Participants 9 Months of Age in Africa","description":"Anti-serotype specific Shigella LPS/OAg serum IgG GMCs were measured by enzyme-linked immunosorbent assay (ELISA) and expressed in ELISA units per milliliter (EU/mL) of serum. Four serotypes were tested. Due to the fact, that the Per protocol set (PPS) for Stage 2 Infants - dose finding cohort had less than the 72 participants per group defined in the protocol as a minimum number of participants to ensure power of the analysis, the Stage 2 Infants Safety cohort and Dose-finding cohort were pooled for the statistical analysis as per the Statistical Analysis Plan. As per protocol, statistical analysis was performed only for the S. sonnei serotype, comparing Stage 2 Infants: Pooled groups (medium vs low dose); and Stage 2 Infants Dose-finding groups (high vs low dose). The objective of this outcome measure is to identify the preferred dose of each component of the altSonflex1-2-3 vaccine for infants 9 months of age in Africa, therefore control groups were not analyzed.","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants which included all eligible participants who received all doses as per protocol,had immunogenicity results post-dose,complied with dosing/blood draw intervals,without intercurrent conditions that may interfere with immunogenicity \\& without prohibited concomitant medication/vaccination.The PPS for immunogenicity was defined by time point.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"ELISA units per milliliter (EU/mL)","timeFrame":"At Day 281 (28 days after the third study intervention)","groups":[{"id":"OG000","title":"Stage 2 Infants: altSonflex1-2-3 Low Dose Pooled","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered either on Day 1 and Day 253 or on Day 29 and Day 281. This group was obtained by pooling the Stage 2 Infants safety cohort: altSonflex1-2-3 Low Dose group and the Stage 2 Infants dose-finding cohort: altSonflex1-2-3 Low Dose group."},{"id":"OG001","title":"Stage 2 Infants: altSonflex1-2-3 Medium Dose Pooled","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered either on Day 1 and Day 253 or on Day 29 and Day 281. This group was obtained by pooling the Stage 2 Infants safety cohort: altSonflex1-2-3 Medium Dose group and the Stage 2 Infants dose-finding cohort: altSonflex1-2-3 Medium Dose group."},{"id":"OG002","title":"Stage 2 Infants: altSonflex1-2-3 High Dose Pooled","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered either on Day 1 and Day 253 or on Day 29 and Day 281. This group was obtained by pooling the Stage 2 Infants safety cohort: altSonflex1-2-3 High Dose group and the Stage 2 Infants dose-finding cohort: altSonflex1-2-3 High Dose group."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG004","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG005","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"75"},{"groupId":"OG001","value":"72"},{"groupId":"OG002","value":"80"},{"groupId":"OG003","value":"66"},{"groupId":"OG004","value":"64"},{"groupId":"OG005","value":"71"}]}],"classes":[{"title":"S. sonnei Ab IgG","categories":[{"measurements":[{"groupId":"OG000","value":"379.3","lowerLimit":"81.4","upperLimit":"1766.5"},{"groupId":"OG001","value":"463.5","lowerLimit":"95.0","upperLimit":"2261.3"},{"groupId":"OG002","value":"457.6","lowerLimit":"94.7","upperLimit":"2211.3"},{"groupId":"OG003","value":"437.3","lowerLimit":"335.3","upperLimit":"570.4"},{"groupId":"OG004","value":"577.5","lowerLimit":"449.7","upperLimit":"741.7"},{"groupId":"OG005","value":"584.3","lowerLimit":"451.9","upperLimit":"755.5"}]}]},{"title":"S. flexneri 1b Ab IgG","categories":[{"measurements":[{"groupId":"OG000","value":"51.1","lowerLimit":"39.3","upperLimit":"66.4"},{"groupId":"OG001","value":"32.1","lowerLimit":"25.6","upperLimit":"40.4"},{"groupId":"OG002","value":"35.6","lowerLimit":"28.3","upperLimit":"44.8"},{"groupId":"OG003","value":"56.6","lowerLimit":"44.0","upperLimit":"72.9"},{"groupId":"OG004","value":"33.1","lowerLimit":"25.1","upperLimit":"43.7"},{"groupId":"OG005","value":"35.1","lowerLimit":"27.0","upperLimit":"45.7"}]}]},{"title":"S. flexneri 2a Ab IgG","categories":[{"measurements":[{"groupId":"OG000","value":"177.8","lowerLimit":"57.4","upperLimit":"550.6"},{"groupId":"OG001","value":"135.3","lowerLimit":"34.0","upperLimit":"537.9"},{"groupId":"OG002","value":"173.8","lowerLimit":"62.4","upperLimit":"484.0"},{"groupId":"OG003","value":"186.3","lowerLimit":"141.2","upperLimit":"245.8"},{"groupId":"OG004","value":"145.9","lowerLimit":"115.2","upperLimit":"184.9"},{"groupId":"OG005","value":"180.8","lowerLimit":"136.9","upperLimit":"238.7"}]}]},{"title":"S. flexneri 3a Ab IgG","categories":[{"measurements":[{"groupId":"OG000","value":"32.6","lowerLimit":"6.1","upperLimit":"173.2"},{"groupId":"OG001","value":"24.4","lowerLimit":"4.8","upperLimit":"125.4"},{"groupId":"OG002","value":"27.5","lowerLimit":"5.0","upperLimit":"152.2"},{"groupId":"OG003","value":"39.7","lowerLimit":"28.9","upperLimit":"54.6"},{"groupId":"OG004","value":"30.4","lowerLimit":"22.3","upperLimit":"41.5"},{"groupId":"OG005","value":"36.6","lowerLimit":"25.8","upperLimit":"51.9"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"To identify the preferred dose of S. sonnei component of the vaccine (medium vs. low) for infants 9 months of age in Africa. The statistical tests to identify the preferred dose among the 3 different dose levels (Dose A, Dose B, and Dose C) in infants were defined according to GMCs dose-response shapes of each of the 4 components as measured by GVGH ELISA. The selection strategy had been predefined for each of the possible scenarios of the dose-response shapes.","nonInferiorityType":"OTHER","nonInferiorityComment":"Non-inferiority or equivalence analysis has not been performed, this is a pair-wise comparison. Results are based on a linear mixed model with fixed effect for treatment, timepoint, baseline value, treatment\\*timepoint, random effect for cohort and a repeated timepoint effect within a participant under an unstructured covariance matrix. Model assumes unequal variances between treatment groups.","pValue":"0.273","statisticalMethod":"t-test, 2 sided","statisticalComment":"Restricted maximum likelihood was used to estimate the variance components, Kenward-Roger approximation was used to calculate the degrees of freedom.","paramType":"Geometric Mean Concentration Ratio","paramValue":"1.22","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.85","ciUpperLimit":"1.75"},{"groupIds":["OG003","OG005"],"groupDescription":"To identify the preferred dose of S. sonnei component of the vaccine (high vs. low) for infants 9 months of age in Africa. The statistical tests to identify the preferred dose among the 3 different dose levels (Dose A, Dose B, and Dose C) in infants were defined according to GMCs dose-response shapes of each of the 4 components as measured by GVGH ELISA. The selection strategy had been predefined for each of the possible scenarios of the dose-response shapes.","nonInferiorityType":"OTHER","nonInferiorityComment":"Non-inferiority or equivalence analysis has not been performed, this is a pair-wise comparison. Results are based on a linear mixed model with fixed effect for treatment, timepoint, baseline value, treatment\\*timepoint, random effect for cohort and a repeated timepoint effect within a participant under an unstructured covariance matrix. Model assumes unequal variances between treatment groups.","pValue":"0.120","pValueComment":"Results are based on a linear mixed model with fixed effect for treatment, timepoint, baseline value, treatment\\*timepoint, random effect for cohort and a repeated timepoint effect within a participant under an unstructured covariance matrix.","statisticalMethod":"t-test, 2 sided","statisticalComment":"Restricted maximum likelihood was used to estimate the variance components, Kenward-Roger approximation was used to calculate the degrees of freedom.","paramType":"Geometric Mean Concentration Ratio","paramValue":"1.34","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.93","ciUpperLimit":"1.93"}]},{"type":"PRIMARY","title":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Solicited Administration Site Events","description":"The solicited administration site events assessed were erythema, pain, and swelling.","populationDescription":"The analysis was performed on the Solicited Safety Set for Stage 1 Adults which included all participants who received at least 1 dose of the study intervention, who have solicited safety data. As the participants in Stage 1 Adults: Placebo Group received the second placebo intervention at Day 85 or at Day 169, the analysis being performed on the pooled participants as per the SAP, no differentiation was made by timepoint of administration for the second dose for this group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 169 [depending on the vaccination schedule])","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"classes":[{"title":"Erythema, Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"1"}]}]},{"title":"Erythema, Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]},{"title":"Erythema, Vaccination at 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"4"}]}]},{"title":"Erythema, Vaccination at Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"Pain, Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"16"}]}]},{"title":"Pain, Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"}]}]},{"title":"Pain, Vaccination at Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"31"}]}]},{"title":"Pain, Vaccination at Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"8"}]}]},{"title":"Swelling, Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"0"}]}]},{"title":"Swelling, Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}]},{"title":"Swelling, Vaccination at 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"5"}]}]},{"title":"Swelling, Vaccination at Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 1: Number of Adults 18 to 50 Years of Age in Europe With Solicited Systemic Events","description":"The solicited systemic event assessed was fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","populationDescription":"The analysis was performed on the Solicited Safety Set for Stage 1 Adults. As the participants in Stage 1 Adults: Placebo Group received the second placebo intervention at Day 85 or at Day 169, the analysis being performed on the pooled participants as per the SAP, no differentiation was made by timepoint of administration for the second dose for this group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 169 [depending on the vaccination schedule])","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"classes":[{"title":"Within 7 days after vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Within 7 days after vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]},{"title":"Within 7 days after vaccination at Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"1"}]}]},{"title":"Within 7 days after vaccination at Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"1"}]}]}]},{"type":"PRIMARY","title":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Unsolicited Adverse Events (AEs)","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","populationDescription":"The analysis was performed on the Unsolicited Safety Set for Stage 1 Adults which included all participants who received at least 1 dose of the study intervention that reported having/not having unsolicited AEs. As the participants in Stage 1 Adults: Placebo Group received the second placebo intervention at Day 85 or at Day 169, the analysis being performed on the pooled participants as per the SAP, no differentiation was made by timepoint of administration for the second dose for this group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 28 days after each study intervention (administered at at Day 1, Day 85 and Day 169 [depending on the vaccination schedule])","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"classes":[{"title":"Within 28 days after vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"25"}]}]},{"title":"Within 28 days after vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"14"}]}]},{"title":"Within 28 days after vaccination at Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"14"}]}]},{"title":"Within 28 days after vaccination at Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"12"}]}]}]},{"type":"PRIMARY","title":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Serious Adverse Events (SAEs)","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","populationDescription":"The analysis was performed on the Exposed Set for Stage 1 Adults which included all participants who received at least 1 dose of the study intervention. As the participants in Stage 1 Adults: Placebo Group received the second placebo intervention at Day 85 or at Day 169, the analysis being performed on the pooled participants as per the SAP, no differentiation was made by timepoint of administration for the second dose for this group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 113 and/or Day 197","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"classes":[{"title":"From Day 1 to Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]},{"title":"From Day 1 to Day 197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"1"}]}]},{"title":"From Day 1 to Day 113/197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention","description":"Panel tests include measures of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and white blood cells (WBC). Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 1 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 8","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"classes":[{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"30"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"}]}]},{"title":"AST, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"}]}]},{"title":"AST, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}]},{"title":"Creatinine, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Basophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Basophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Basophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"}]}]},{"title":"Basophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Eosinophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"31"}]}]},{"title":"Eosinophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Eosinophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Erythrocytes, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Erythrocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Erythrocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"33"}]}]},{"title":"Erythrocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Haematocrit, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haematocrit, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"33"}]}]},{"title":"Haematocrit, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haematocrit, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"33"}]}]},{"title":"Haemoglobin, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Haemoglobin, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"31"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"Monocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Monocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Monocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Below, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"32"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"Neutrophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Platelets, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"29"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"WBC, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"32"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 1: Number of Participants 18 to 50 Years of Age in Europe With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 85/Day 169 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 1 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 92 (Stage 1 Adults: altSonflex1-2-3 High Dose Group 1), at Day 176 (Stage 1 Adults: altSonflex1-2-3 High Dose Group 2) and at Day 92/Day 176 (Stage 1 Adults: Placebo Group)","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"28"}]}],"classes":[{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"26"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"27"}]}]},{"title":"AST, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"AST, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"AST, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"27"}]}]},{"title":"Creatinine, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Basophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Basophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Basophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"}]}]},{"title":"Basophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Eosinophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"24"}]}]},{"title":"Eosinophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Erythrocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"27"}]}]},{"title":"Erythrocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Erythrocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haematocrit, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haematocrit, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"28"}]}]},{"title":"Haematocrit, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"28"}]}]},{"title":"Haemoglobin, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Lymphocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"27"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Monocytes, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Monocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"23"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]}]},{"title":"Neutrophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"22"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]}]},{"title":"Neutrophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Platelets, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Platelets, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"23"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"24"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Solicited Administration Site Events","description":"The solicited administration site events assessed were pain, erythema, and swelling.","populationDescription":"The analysis was performed on the Solicited Safety Set for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1 and Day 85)","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"title":"Pain, Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"}]}]},{"title":"Pain, Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"}]}]},{"title":"Erythema, Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"Erythema, Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"Swelling, Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"Swelling, Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Solicited Systemic Events","description":"The solicited systemic event assessed was fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","populationDescription":"The analysis was performed on the Solicited Safety Set for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1 and Day 85)","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"title":"Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Unsolicited Adverse Events (AEs)","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","populationDescription":"The analysis was performed on the Unsolicited Safety Set for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 28 days after each study intervention (administered at Day 1 and Day 85)","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"title":"Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}]}]},{"title":"Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Serious Adverse Events (SAEs)","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 113","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 8","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"title":"ALT, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"}]}]},{"title":"Creatinine, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Creatinine, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"Creatinine, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"Eosinophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"Lymphocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"}]}]},{"title":"Lymphocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"Monocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 18 to 50 Years of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 85 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 92","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"AST, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"10"}]}]},{"title":"AST, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"}]}]},{"title":"Creatinine, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"}]}]},{"title":"Creatinine, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"Eosinophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]},{"title":"Lymphocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"}]}]},{"title":"Lymphocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"10"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Neutrophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"10"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"WBC, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Solicited Administration Site Events","description":"The solicited administration site events assessed were erythema, pain, and swelling.","populationDescription":"The analysis was performed on the Solicited Safety Set for Stage 2 Children.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1 and Day 85)","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"title":"Erythema, Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Erythema, Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Pain, Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Pain, Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Swelling, Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Swelling, Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Solicited Systemic Events","description":"The solicited systemic event assessed was fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","populationDescription":"The analysis was performed on the Solicited Safety Set for Stage 2 Children.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1 and Day 85)","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"title":"Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Unsolicited Adverse Events (AEs)","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","populationDescription":"The analysis was performed on the Unsolicited Safety Set for Stage 2: Children.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 28 days after each study intervention (administered at Day 1 and Day 85)","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"title":"Vaccination at Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"8"}]}]},{"title":"Vaccination at Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Serious Adverse Events (SAEs)","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Children.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 113","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Children.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 8","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"16"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"ALT, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}]},{"title":"AST, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"17"}]}]},{"title":"Creatinine, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Creatinine, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Basophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"16"}]}]},{"title":"Basophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"Basophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Eosinophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"12"}]}]},{"title":"Eosinophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"5"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"12"}]}]},{"title":"Erythrocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Erythrocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"5"}]}]},{"title":"Erythrocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"}]}]},{"title":"Haematocrit, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"14"}]}]},{"title":"Haematocrit, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Haematocrit, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"5"}]}]},{"title":"Haemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"18"}]}]},{"title":"Haemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haemoglobin, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"8"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"Lymphocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"7"}]}]},{"title":"Lymphocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"13"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Monocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"}]}]},{"title":"Neutrophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"16"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"4"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"10"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"19"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 24 to 59 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 85 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Children.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 92","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"15"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"19"}]}]},{"title":"AST, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"18"}]}]},{"title":"Creatinine, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"20"}]}]},{"title":"Basophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Basophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Eosinophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"16"}]}]},{"title":"Eosinophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Eosinophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Erythrocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"17"}]}]},{"title":"Erythrocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Erythrocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Erythrocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"Haematocrit, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Haematocrit, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"19"}]}]},{"title":"Haemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Haemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"18"}]}]},{"title":"Haemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"14"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"Lymphocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Lymphocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Monocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"13"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"4"}]}]},{"title":"Monocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"18"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"7"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"5"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"6"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"19"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Solicited Administration Site Events - Infants Safety Cohort","description":"The solicited administration site events assessed were erythema, pain, and swelling.","populationDescription":"The analysis was performed on the solicited Safety Set for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 253)","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"classes":[{"title":"Erythema, Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythema, Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Erythema, Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"}]}]},{"title":"Pain, Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"3"}]}]},{"title":"Pain, Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"3"}]}]},{"title":"Pain, Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"6"}]}]},{"title":"Swelling, Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"2"}]}]},{"title":"Swelling, Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Swelling, Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Solicited Administration Site Events - Infants Dose-finding Cohort","description":"The solicited administration site events assessed were erythema, pain, and swelling.","populationDescription":"The analysis was performed on the Solicited Safety Set for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 253)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"80"},{"groupId":"OG001","value":"79"},{"groupId":"OG002","value":"82"},{"groupId":"OG003","value":"81"}]}],"classes":[{"title":"Erythema, Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"80"},{"groupId":"OG001","value":"79"},{"groupId":"OG002","value":"82"},{"groupId":"OG003","value":"81"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"9"}]}]},{"title":"Erythema, Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"72"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"4"}]}]},{"title":"Erythema, Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"8"}]}]},{"title":"Pain, Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"80"},{"groupId":"OG001","value":"79"},{"groupId":"OG002","value":"82"},{"groupId":"OG003","value":"81"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"42"},{"groupId":"OG002","value":"43"},{"groupId":"OG003","value":"14"}]}]},{"title":"Pain, Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"72"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"36"},{"groupId":"OG002","value":"43"},{"groupId":"OG003","value":"20"}]}]},{"title":"Pain, Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"41"},{"groupId":"OG003","value":"26"}]}]},{"title":"Swelling, Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"80"},{"groupId":"OG001","value":"79"},{"groupId":"OG002","value":"82"},{"groupId":"OG003","value":"81"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"9"}]}]},{"title":"Swelling, Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"72"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"2"}]}]},{"title":"Swelling, Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"17"},{"groupId":"OG003","value":"14"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Solicited Systemic Events - Infants Safety Cohort","description":"The solicited systemic event is fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","populationDescription":"The analysis was performed on the Solicited Safety Set for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 253)","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"classes":[{"title":"Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"5"}]}]},{"title":"Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"4"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Solicited Systemic Events - Infants Dose-finding Cohort","description":"The solicited systemic event is fever. Fever is defined as temperature equal to or above (=\\>) 38.0°C.","populationDescription":"The analysis was performed on the Solicited Safety Set for Stage 2 Infants, dose finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days after each study intervention (administered at Day 1, Day 85 and Day 253)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"80"},{"groupId":"OG001","value":"79"},{"groupId":"OG002","value":"82"},{"groupId":"OG003","value":"81"}]}],"classes":[{"title":"Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"80"},{"groupId":"OG001","value":"79"},{"groupId":"OG002","value":"82"},{"groupId":"OG003","value":"81"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"7"}]}]},{"title":"Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"72"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"17"}]}]},{"title":"Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"9"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Unsolicited Adverse Events (AEs) - Infants Safety Cohort","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","populationDescription":"The analysis was performed on the Unsolicited Safety Set for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 28 days after each study intervention (administered at Day 1, Day 85 and Day 253)","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"classes":[{"title":"Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"17"}]}]},{"title":"Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"10"}]}]},{"title":"Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"4"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Unsolicited Adverse Events (AEs) - Infants Dose-finding Cohort","description":"An unsolicited AE is defined as an AE reported in addition to those solicited during the clinical study. Also, any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms is reported as an unsolicited adverse event.","populationDescription":"The analysis was performed on the Unsolicited Safety Set for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 28 days after each study intervention (administered at Day 1, Day 85 and Day 253)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"classes":[{"title":"Vaccination at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"37"},{"groupId":"OG002","value":"34"},{"groupId":"OG003","value":"41"}]}]},{"title":"Vaccination at Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"72"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"28"}]}]},{"title":"Vaccination at Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"26"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Serious Adverse Events (SAEs) - Infants Safety Cohort","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 281","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Serious Adverse Events (SAEs) - Infants Dose-finding Cohort","description":"An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in disability/incapacity, is a congenital anomaly/birth defect in the offspring of a study participant, results in abnormal pregnancy outcomes or any other situation based on appropriate medical or scientific judgement.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 1 to Day 281","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention - Infants Safety Cohort","description":"Panel tests include measures of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, potassium, sodium, urea, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and white blood cells (WBC). Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 8","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"classes":[{"title":"ALT, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"29"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"18"}]}]},{"title":"Basophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Basophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Basophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"9"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}]},{"title":"Eosinophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"24"}]}]},{"title":"Erythrocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythrocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythrocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"4"}]}]},{"title":"Haematocrit, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"25"}]}]},{"title":"Haematocrit, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Haematocrit, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"23"}]}]},{"title":"Haemoglobin, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"15"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"5"}]}]},{"title":"Lymphocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Lymphocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"7"}]}]},{"title":"Monocytes, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Monocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"23"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"3"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"Monocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"24"}]}]},{"title":"Neutrophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"16"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"WBC, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"22"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"4"}]}]},{"title":"WBC, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After First Study Intervention - Infants Dose-finding Cohort","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Infants.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 8","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"76"},{"groupId":"OG002","value":"82"},{"groupId":"OG003","value":"81"}]}],"classes":[{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"75"},{"groupId":"OG002","value":"79"},{"groupId":"OG003","value":"80"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"76"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"81"}]}]},{"title":"AST, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"76"},{"groupId":"OG002","value":"81"},{"groupId":"OG003","value":"81"}]}]},{"title":"Creatinine, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Potassium, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Potassium, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Potassium, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"76"},{"groupId":"OG002","value":"81"},{"groupId":"OG003","value":"78"}]}]},{"title":"Potassium, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Potassium, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Sodium, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"35"},{"groupId":"OG002","value":"39"},{"groupId":"OG003","value":"37"}]}]},{"title":"Sodium, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"19"}]}]},{"title":"Sodium, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"14"}]}]},{"title":"Sodium, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"11"}]}]},{"title":"Urea, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"36"},{"groupId":"OG003","value":"25"}]}]},{"title":"Urea, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"16"},{"groupId":"OG003","value":"14"}]}]},{"title":"Urea, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"15"}]}]},{"title":"Urea, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"27"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"70"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"68"}]}]},{"title":"Basophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"5"}]}]},{"title":"Basophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"6"}]}]},{"title":"Basophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Eosinophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"}]}]},{"title":"Eosinophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"3"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"65"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"66"}]}]},{"title":"Eosinophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Eosinophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"4"}]}]},{"title":"Eosinophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"4"}]}]},{"title":"Erythrocytes, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Erythrocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]}]},{"title":"Erythrocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"52"},{"groupId":"OG003","value":"53"}]}]},{"title":"Erythrocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"5"}]}]},{"title":"Erythrocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"}]}]},{"title":"Erythrocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"13"},{"groupId":"OG003","value":"17"}]}]},{"title":"Haematocrit, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"4"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"66"}]}]},{"title":"Haematocrit, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haematocrit, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"5"}]}]},{"title":"Haematocrit, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"3"}]}]},{"title":"Haemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"5"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"68"},{"groupId":"OG003","value":"67"}]}]},{"title":"Haemoglobin, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Haemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Haemoglobin, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Lymphocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"51"},{"groupId":"OG001","value":"54"},{"groupId":"OG002","value":"58"},{"groupId":"OG003","value":"51"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"3"}]}]},{"title":"Lymphocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"14"}]}]},{"title":"Lymphocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"12"}]}]},{"title":"Monocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"51"},{"groupId":"OG003","value":"50"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"18"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"5"}]}]},{"title":"Monocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"7"}]}]},{"title":"Neutrophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"7"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"11"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"49"},{"groupId":"OG002","value":"56"},{"groupId":"OG003","value":"56"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Neutrophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Platelets, Below, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"18"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"6"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"15"},{"groupId":"OG003","value":"16"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"41"},{"groupId":"OG003","value":"41"}]}]},{"title":"WBC, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"60"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"7"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"6"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention - Infants Safety Cohort","description":"Panel tests include measures of ALT, AST, creatinine, potassium, sodium, urea, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Infants, safety cohort. Potassium, sodium and urea have been collected only after Protocol Amendment 4 was effective, therefore there is no data to report for Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose and Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose groups.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 92","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"classes":[{"title":"ALT, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALT, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"28"}]}]},{"title":"ALT, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"28"}]}]},{"title":"AST, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Creatinine, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}]},{"title":"Potassium, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"6"}]}]},{"title":"Potassium, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"3"}]}]},{"title":"Potassium, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Potassium, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Sodium, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"9"}]}]},{"title":"Sodium, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Sodium, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]}]},{"title":"Urea, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"3"}]}]},{"title":"Urea, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Urea, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Urea, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]}]},{"title":"Basophils, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"12"}]}]},{"title":"Basophils, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"5"}]}]},{"title":"Basophils, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Basophils, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"10"}]}]},{"title":"Eosinophils, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Eosinophils, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"24"}]}]},{"title":"Eosinophils, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Eosinophils, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Eosinophils, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythrocytes, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythrocytes, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythrocytes, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"19"}]}]},{"title":"Erythrocytes, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythrocytes, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Erythrocytes, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"4"}]}]},{"title":"Haematocrit, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Haematocrit, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Haematocrit, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"21"}]}]},{"title":"Haematocrit, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Haematocrit, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haematocrit, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Haemoglobin, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"26"}]}]},{"title":"Haemoglobin, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Lymphocytes, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"14"}]}]},{"title":"Lymphocytes, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"3"}]}]},{"title":"Lymphocytes, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Lymphocytes, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"10"}]}]},{"title":"Monocytes, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Monocytes, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Monocytes, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"24"}]}]},{"title":"Monocytes, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Monocytes, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Neutrophils, Below, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Neutrophils, Within, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Neutrophils, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"22"}]}]},{"title":"Neutrophils, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Platelets, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"7"}]}]},{"title":"Platelets, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Platelets, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"4"}]}]},{"title":"Platelets, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"15"}]}]},{"title":"WBC, Below, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"WBC, Below, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"WBC, Within, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"18"}]}]},{"title":"WBC, Within, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC, Above, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"5"}]}]},{"title":"WBC, Above, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Second Study Intervention - Infants Dose-finding Cohort","description":"Panel tests include measures of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, potassium, sodium, urea, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and white blood cells (WBC). Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 92","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"72"},{"groupId":"OG002","value":"74"},{"groupId":"OG003","value":"73"}]}],"classes":[{"title":"ALT, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALT, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALT, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"68"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"72"}]}]},{"title":"AST, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"74"},{"groupId":"OG003","value":"72"}]}]},{"title":"Creatinine, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Potassium, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"19"}]}]},{"title":"Potassium, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"34"},{"groupId":"OG003","value":"28"}]}]},{"title":"Potassium, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"10"}]}]},{"title":"Potassium, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"22"},{"groupId":"OG002","value":"20"},{"groupId":"OG003","value":"16"}]}]},{"title":"Sodium, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"52"}]}]},{"title":"Sodium, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"}]}]},{"title":"Sodium, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"13"}]}]},{"title":"Sodium, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Urea, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"24"}]}]},{"title":"Urea, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"11"}]}]},{"title":"Urea, Below, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Urea, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"13"},{"groupId":"OG003","value":"13"}]}]},{"title":"Urea, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"25"}]}]},{"title":"Basophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Basophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"64"},{"groupId":"OG003","value":"54"}]}]},{"title":"Basophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"8"}]}]},{"title":"Basophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"5"}]}]},{"title":"Basophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"}]}]},{"title":"Eosinophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Eosinophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"60"},{"groupId":"OG002","value":"62"},{"groupId":"OG003","value":"61"}]}]},{"title":"Eosinophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"4"}]}]},{"title":"Eosinophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Eosinophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"5"}]}]},{"title":"Erythrocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Erythrocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"50"}]}]},{"title":"Erythrocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"}]}]},{"title":"Erythrocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"7"}]}]},{"title":"Erythrocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"13"}]}]},{"title":"Haematocrit, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haematocrit, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Haematocrit, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"60"},{"groupId":"OG002","value":"57"},{"groupId":"OG003","value":"62"}]}]},{"title":"Haematocrit, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haematocrit, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"3"}]}]},{"title":"Haemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"4"}]}]},{"title":"Haemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"7"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"56"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"57"}]}]},{"title":"Haemoglobin, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haemoglobin, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"}]}]},{"title":"Lymphocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"36"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"9"}]}]},{"title":"Lymphocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"11"}]}]},{"title":"Lymphocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"16"}]}]},{"title":"Monocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Monocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"47"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"62"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"2"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"4"}]}]},{"title":"Monocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"3"}]}]},{"title":"Neutrophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"6"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"60"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Neutrophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Neutrophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"15"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"16"},{"groupId":"OG003","value":"5"}]}]},{"title":"Platelets, Above, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"7"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"37"},{"groupId":"OG002","value":"40"},{"groupId":"OG003","value":"46"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"3"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"48"},{"groupId":"OG002","value":"56"},{"groupId":"OG003","value":"53"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"7"}]}]},{"title":"WBC, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"6"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Third Study Intervention - Infants Safety Cohort","description":"Panel tests include measures of ALT, AST, creatinine, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and WBC. Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 260","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"28"}]}],"classes":[{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}]},{"title":"ALT, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"28"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"28"}]}]},{"title":"Creatinine, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Potassium, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"11"}]}]},{"title":"Potassium, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"5"}]}]},{"title":"Potassium, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"7"}]}]},{"title":"Potassium, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"}]}]},{"title":"Sodium, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"18"}]}]},{"title":"Sodium, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Sodium, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"}]}]},{"title":"Sodium, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Urea, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"9"}]}]},{"title":"Urea, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Urea, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"}]}]},{"title":"Urea, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"13"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"23"}]}]},{"title":"Basophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Basophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Basophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Eosinophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"22"}]}]},{"title":"Eosinophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Eosinophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Erythrocytes, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"20"}]}]},{"title":"Erythrocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Erythrocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]}]},{"title":"Erythrocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"4"}]}]},{"title":"Haematocrit, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haematocrit, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"16"}]}]},{"title":"Haematocrit, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haematocrit, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haematocrit, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"5"}]}]},{"title":"Haemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]}]},{"title":"Haemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"17"}]}]},{"title":"Haemoglobin, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haemoglobin, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"21"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Lymphocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Lymphocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]}]},{"title":"Monocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Monocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"22"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Monocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"24"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"6"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"5"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"12"}]}]},{"title":"WBC, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"18"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]}]},{"title":"WBC, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]}]},{"type":"PRIMARY","title":"Stage 2: Number of Participants 9 Months of Age in Africa With Deviations From Normal Values of Haematological, Renal, and Hepatic Panel Test Results After Third Study Intervention - Infants Dose-finding Cohort","description":"Panel tests include measures of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, potassium, sodium, urea, basophils, eosinophils, erythrocytes, haematocrit, haemoglobin, lymphocytes, monocytes, neutrophils, platelets and white blood cells (WBC). Categories reported when comparing Day 1 (baseline) and normal range hematological, renal and hepatic laboratory results are defined as follows: \\<parameter\\>,\\<range at baseline\\>,\\<range at timing\\>, where range is being classified as Below = value below; Within = value within; and Above = value above the laboratory reference range defined for the specified visit and laboratory parameter.","populationDescription":"The analysis was performed on the Exposed Set for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 260","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"classes":[{"title":"ALT, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"ALT, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALT, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"67"},{"groupId":"OG002","value":"69"},{"groupId":"OG003","value":"65"}]}]},{"title":"ALT, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALT, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALT, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"4"}]}]},{"title":"AST, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"70"}]}]},{"title":"AST, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"AST, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Creatinine, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"70"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}]},{"title":"Creatinine, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Creatinine, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Potassium, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"21"}]}]},{"title":"Potassium, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"23"}]}]},{"title":"Potassium, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"10"}]}]},{"title":"Potassium, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"17"}]}]},{"title":"Sodium, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"2"}]}]},{"title":"Sodium, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Sodium, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"63"}]}]},{"title":"Sodium, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"2"}]}]},{"title":"Sodium, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"4"}]}]},{"title":"Sodium, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Urea, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"16"},{"groupId":"OG003","value":"13"}]}]},{"title":"Urea, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"12"}]}]},{"title":"Urea, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"5"}]}]},{"title":"Urea, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"36"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"41"}]}]},{"title":"Basophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Basophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"54"},{"groupId":"OG002","value":"62"},{"groupId":"OG003","value":"53"}]}]},{"title":"Basophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"}]}]},{"title":"Basophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"3"}]}]},{"title":"Basophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"6"}]}]},{"title":"Eosinophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Eosinophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Eosinophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"56"}]}]},{"title":"Eosinophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"Eosinophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"3"}]}]},{"title":"Eosinophils, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"7"}]}]},{"title":"Erythrocytes, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Erythrocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"44"}]}]},{"title":"Erythrocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"}]}]},{"title":"Erythrocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"5"}]}]},{"title":"Erythrocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"17"}]}]},{"title":"Haematocrit, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Haematocrit, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Haematocrit, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"55"},{"groupId":"OG002","value":"56"},{"groupId":"OG003","value":"57"}]}]},{"title":"Haematocrit, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haematocrit, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"7"}]}]},{"title":"Haematocrit, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"5"}]}]},{"title":"Haemoglobin, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"4"}]}]},{"title":"Haemoglobin, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"Haemoglobin, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"57"},{"groupId":"OG003","value":"59"}]}]},{"title":"Haemoglobin, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"}]}]},{"title":"Haemoglobin, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"2"}]}]},{"title":"Haemoglobin, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Lymphocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"57"},{"groupId":"OG002","value":"58"},{"groupId":"OG003","value":"48"}]}]},{"title":"Lymphocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"8"}]}]},{"title":"Lymphocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"}]}]},{"title":"Lymphocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"7"}]}]},{"title":"Monocytes, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Monocytes, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Monocytes, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"Monocytes, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"63"},{"groupId":"OG003","value":"62"}]}]},{"title":"Monocytes, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"}]}]},{"title":"Monocytes, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"Monocytes, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"6"}]}]},{"title":"Neutrophils, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"}]}]},{"title":"Neutrophils, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"60"},{"groupId":"OG002","value":"58"},{"groupId":"OG003","value":"58"}]}]},{"title":"Neutrophils, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Neutrophils, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Platelets, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"16"}]}]},{"title":"Platelets, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"17"},{"groupId":"OG003","value":"11"}]}]},{"title":"Platelets, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"6"}]}]},{"title":"Platelets, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"38"}]}]},{"title":"WBC, Below, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC, Below, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC, Within, Below","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC, Within, Within","categories":[{"measurements":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"53"}]}]},{"title":"WBC, Within, Above","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"6"}]}]},{"title":"WBC, Above, Within","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"}]}]},{"title":"WBC, Above, Above","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"4"}]}]}]},{"type":"SECONDARY","title":"Stage 1: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 18 to 50 Years of Age in Europe","description":"Anti-serotype specific Shigella LPS/OAg serum IgG GMCs were measured by ELISA and expressed in EU/mL of serum. S. sonnei, S. flexneri 1b, S. flexneri 2a, and S. flexneri 3a serotypes were tested.","populationDescription":"The analysis was performed on the PPS for Stage 1 Adults. As the participants in Stage 1 Adults: Placebo Group received the second placebo intervention at Day 85 or at Day 169, the analysis being performed on the pooled participants as per the SAP, no differentiation was made by timepoint of administration for the second dose for this group.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"EU/mL","timeFrame":"At Day 1 and Day 85/Day 169(before each study intervention); at Day 15 (14 days after the first study intervention); at Day 29 and Day 113/Day 197 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15.3","lowerLimit":"10.8","upperLimit":"21.8"},{"groupId":"OG001","value":"8.9","lowerLimit":"6.9","upperLimit":"11.5"},{"groupId":"OG002","value":"21.0","lowerLimit":"13.2","upperLimit":"33.6"}]}]},{"title":"S sonnei Ab IgG, Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"307.5","lowerLimit":"167.3","upperLimit":"565.2"},{"groupId":"OG001","value":"170.7","lowerLimit":"98.2","upperLimit":"296.5"},{"groupId":"OG002","value":"18.4","lowerLimit":"11.6","upperLimit":"29.3"}]}]},{"title":"S sonnei Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"325.3","lowerLimit":"181.6","upperLimit":"582.8"},{"groupId":"OG001","value":"172.1","lowerLimit":"96.7","upperLimit":"306.4"},{"groupId":"OG002","value":"18.1","lowerLimit":"11.5","upperLimit":"28.6"}]}]},{"title":"S sonnei Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"287.6","lowerLimit":"144.1","upperLimit":"574.1"}]}]},{"title":"S sonnei Ab IgG, Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"94.8","lowerLimit":"55.2","upperLimit":"162.9"}]}]},{"title":"S sonnei Ab IgG, Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"19.0","lowerLimit":"11.1","upperLimit":"32.3"}]}]},{"title":"S sonnei Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"387.8","lowerLimit":"206.6","upperLimit":"727.8"}]}]},{"title":"S sonnei Ab IgG, Day 197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"167.2","lowerLimit":"104.3","upperLimit":"267.9"}]}]},{"title":"S sonnei Ab IgG, Day 113/197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"19.9","lowerLimit":"11.8","upperLimit":"33.7"}]}]},{"title":"S flexneri 1b Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23.5","lowerLimit":"13.6","upperLimit":"40.5"},{"groupId":"OG001","value":"22.9","lowerLimit":"13.9","upperLimit":"37.8"},{"groupId":"OG002","value":"26.9","lowerLimit":"15.3","upperLimit":"47.3"}]}]},{"title":"S flexneri 1b Ab IgG, Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"123.1","lowerLimit":"71.8","upperLimit":"211.1"},{"groupId":"OG001","value":"102.1","lowerLimit":"63.8","upperLimit":"163.5"},{"groupId":"OG002","value":"27.4","lowerLimit":"16.1","upperLimit":"46.7"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"118.3","lowerLimit":"70.5","upperLimit":"198.5"},{"groupId":"OG001","value":"90.2","lowerLimit":"55.9","upperLimit":"145.5"},{"groupId":"OG002","value":"27.0","lowerLimit":"15.8","upperLimit":"46.3"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"79.1","lowerLimit":"45.3","upperLimit":"138.1"}]}]},{"title":"S flexneri 1b Ab IgG, Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"48.5","lowerLimit":"30.1","upperLimit":"78.0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"27.2","lowerLimit":"15.5","upperLimit":"47.7"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"129.7","lowerLimit":"79.6","upperLimit":"211.5"}]}]},{"title":"S flexneri 1b Ab IgG, Day 197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"73.0","lowerLimit":"48.6","upperLimit":"109.7"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113/197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"26.1","lowerLimit":"14.6","upperLimit":"46.9"}]}]},{"title":"S flexneri 2a Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"33.3","lowerLimit":"23.1","upperLimit":"47.9"},{"groupId":"OG001","value":"32.7","lowerLimit":"22.2","upperLimit":"48.2"},{"groupId":"OG002","value":"44.5","lowerLimit":"27.3","upperLimit":"72.6"}]}]},{"title":"S flexneri 2a Ab IgG, Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"608.0","lowerLimit":"432.4","upperLimit":"854.9"},{"groupId":"OG001","value":"635.2","lowerLimit":"459.5","upperLimit":"878.1"},{"groupId":"OG002","value":"44.3","lowerLimit":"27.4","upperLimit":"71.6"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"545.8","lowerLimit":"393.1","upperLimit":"757.6"},{"groupId":"OG001","value":"582.6","lowerLimit":"424.1","upperLimit":"800.4"},{"groupId":"OG002","value":"42.8","lowerLimit":"26.3","upperLimit":"69.5"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"411.8","lowerLimit":"300.4","upperLimit":"564.6"}]}]},{"title":"S flexneri 2a Ab IgG, Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"364.9","lowerLimit":"259.9","upperLimit":"512.5"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"41.4","lowerLimit":"23.3","upperLimit":"73.6"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"473.6","lowerLimit":"351.1","upperLimit":"638.8"}]}]},{"title":"S flexneri 2a Ab IgG, Day 197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"451.0","lowerLimit":"327.8","upperLimit":"620.6"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113/197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"43.8","lowerLimit":"25.1","upperLimit":"76.3"}]}]},{"title":"S flexneri 3a Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17.3","lowerLimit":"11.1","upperLimit":"27.0"},{"groupId":"OG001","value":"14.2","lowerLimit":"8.4","upperLimit":"23.9"},{"groupId":"OG002","value":"19.9","lowerLimit":"13.1","upperLimit":"30.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"59.1","lowerLimit":"40.5","upperLimit":"86.1"},{"groupId":"OG001","value":"63.8","lowerLimit":"36.2","upperLimit":"112.4"},{"groupId":"OG002","value":"18.4","lowerLimit":"12.2","upperLimit":"27.8"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"56.7","lowerLimit":"37.6","upperLimit":"85.4"},{"groupId":"OG001","value":"60.6","lowerLimit":"34.8","upperLimit":"105.5"},{"groupId":"OG002","value":"19.3","lowerLimit":"12.7","upperLimit":"29.4"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26.9","lowerLimit":"16.7","upperLimit":"43.4"}]}]},{"title":"S flexneri 3a Ab IgG, Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"24.7","lowerLimit":"14.1","upperLimit":"43.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"10.1","lowerLimit":"6.4","upperLimit":"15.9"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"43.1","lowerLimit":"26.9","upperLimit":"69.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"37.2","lowerLimit":"22.4","upperLimit":"61.7"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113/197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"9.2","lowerLimit":"5.6","upperLimit":"15.0"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 18 to 50 Years of Age in Africa","populationDescription":"The analysis was performed on the PPS for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"EU/mL","timeFrame":"At Day 1 and Day 85 (before each study intervention administration) and Day 29 and Day 113 (28 days after each study intervention administration)","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"166.4","lowerLimit":"82.8","upperLimit":"334.2"},{"groupId":"OG001","value":"171.2","lowerLimit":"65.0","upperLimit":"450.6"}]}]},{"title":"S sonnei Ab IgG, Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"3112.0","lowerLimit":"2181.6","upperLimit":"4439.2"},{"groupId":"OG001","value":"172.0","lowerLimit":"66.7","upperLimit":"443.6"}]}]},{"title":"S sonnei Ab IgG, Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"2046.5","lowerLimit":"1372.1","upperLimit":"3052.5"},{"groupId":"OG001","value":"182.1","lowerLimit":"73.2","upperLimit":"453.1"}]}]},{"title":"S sonnei Ab IgG, Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"1974.4","lowerLimit":"1288.5","upperLimit":"3025.6"},{"groupId":"OG001","value":"172.3","lowerLimit":"68.8","upperLimit":"431.6"}]}]},{"title":"S flexneri 1b Ab IgG, Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"194.7","lowerLimit":"44.0","upperLimit":"862.2"},{"groupId":"OG001","value":"106.4","lowerLimit":"41.0","upperLimit":"276.2"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"388.5","lowerLimit":"98.6","upperLimit":"1531.3"},{"groupId":"OG001","value":"103.3","lowerLimit":"40.2","upperLimit":"265.8"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"328.0","lowerLimit":"84.8","upperLimit":"1268.8"},{"groupId":"OG001","value":"110.8","lowerLimit":"38.9","upperLimit":"315.5"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"358.3","lowerLimit":"98.6","upperLimit":"1301.7"},{"groupId":"OG001","value":"107.2","lowerLimit":"37.5","upperLimit":"306.1"}]}]},{"title":"S flexneri 2a Ab IgG, Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"192.3","lowerLimit":"93.7","upperLimit":"394.6"},{"groupId":"OG001","value":"155.8","lowerLimit":"70.7","upperLimit":"343.6"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"563.0","lowerLimit":"269.1","upperLimit":"1177.7"},{"groupId":"OG001","value":"146.1","lowerLimit":"68.7","upperLimit":"311.0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"463.0","lowerLimit":"220.3","upperLimit":"973.4"},{"groupId":"OG001","value":"158.1","lowerLimit":"67.7","upperLimit":"369.3"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"538.6","lowerLimit":"269.9","upperLimit":"1074.7"},{"groupId":"OG001","value":"154.0","lowerLimit":"68.5","upperLimit":"346.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"84.8","lowerLimit":"34.5","upperLimit":"208.8"},{"groupId":"OG001","value":"61.3","lowerLimit":"19.6","upperLimit":"192.0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"212.8","lowerLimit":"89.9","upperLimit":"503.6"},{"groupId":"OG001","value":"57.4","lowerLimit":"18.2","upperLimit":"181.5"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"174.4","lowerLimit":"75.1","upperLimit":"405.3"},{"groupId":"OG001","value":"62.3","lowerLimit":"16.7","upperLimit":"233.3"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"225.4","lowerLimit":"103.2","upperLimit":"492.7"},{"groupId":"OG001","value":"61.6","lowerLimit":"16.7","upperLimit":"226.8"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 24 to 59 Months of Age in Africa","populationDescription":"The analysis was performed on the PPS for Stage 2 Children.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"EU/mL","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"22.7","lowerLimit":"8.5","upperLimit":"61.0"},{"groupId":"OG001","value":"39.1","lowerLimit":"9.5","upperLimit":"160.1"},{"groupId":"OG002","value":"20.7","lowerLimit":"10.5","upperLimit":"41.0"}]}]},{"title":"S sonnei Ab IgG, Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"899.0","lowerLimit":"122.7","upperLimit":"6588.6"},{"groupId":"OG001","value":"746.9","lowerLimit":"93.9","upperLimit":"5940.9"},{"groupId":"OG002","value":"19.3","lowerLimit":"10.4","upperLimit":"35.8"}]}]},{"title":"S sonnei Ab IgG, Day 85)","categories":[{"measurements":[{"groupId":"OG000","value":"702.7","lowerLimit":"125.7","upperLimit":"3927.4"},{"groupId":"OG001","value":"388.2","lowerLimit":"56.6","upperLimit":"2663.4"},{"groupId":"OG002","value":"24.7","lowerLimit":"11.1","upperLimit":"54.7"}]}]},{"title":"S sonnei Ab IgG, Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"1163.2","lowerLimit":"289.8","upperLimit":"4668.7"},{"groupId":"OG001","value":"560.2","lowerLimit":"86.0","upperLimit":"3651.0"},{"groupId":"OG002","value":"40.2","lowerLimit":"15.9","upperLimit":"101.6"}]}]},{"title":"S flexneri 1b Ab IgG, Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"28.6","lowerLimit":"6.6","upperLimit":"123.1"},{"groupId":"OG001","value":"38.4","lowerLimit":"7.0","upperLimit":"211.4"},{"groupId":"OG002","value":"37.0","lowerLimit":"16.4","upperLimit":"83.3"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"74.0","lowerLimit":"23.3","upperLimit":"234.8"},{"groupId":"OG001","value":"119.4","lowerLimit":"27.2","upperLimit":"525.1"},{"groupId":"OG002","value":"33.4","lowerLimit":"13.6","upperLimit":"81.7"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"39.3","lowerLimit":"10.7","upperLimit":"144.5"},{"groupId":"OG001","value":"65.4","lowerLimit":"13.1","upperLimit":"326.7"},{"groupId":"OG002","value":"34.5","lowerLimit":"15.0","upperLimit":"79.6"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"66.7","lowerLimit":"20.5","upperLimit":"217.0"},{"groupId":"OG001","value":"100.3","lowerLimit":"21.6","upperLimit":"466.4"},{"groupId":"OG002","value":"31.9","lowerLimit":"14.0","upperLimit":"72.4"}]}]},{"title":"S flexneri 2a Ab IgG, Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"24.5","lowerLimit":"5.1","upperLimit":"117.9"},{"groupId":"OG001","value":"21.0","lowerLimit":"4.7","upperLimit":"93.0"},{"groupId":"OG002","value":"30.9","lowerLimit":"12.4","upperLimit":"77.3"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"219.2","lowerLimit":"65.6","upperLimit":"732.9"},{"groupId":"OG001","value":"193.5","lowerLimit":"76.2","upperLimit":"491.6"},{"groupId":"OG002","value":"30.6","lowerLimit":"12.7","upperLimit":"74.2"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"101.2","lowerLimit":"28.7","upperLimit":"356.9"},{"groupId":"OG001","value":"103.8","lowerLimit":"36.3","upperLimit":"297.0"},{"groupId":"OG002","value":"32.1","lowerLimit":"14.2","upperLimit":"72.5"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"267.3","lowerLimit":"101.0","upperLimit":"707.4"},{"groupId":"OG001","value":"290.0","lowerLimit":"115.0","upperLimit":"731.3"},{"groupId":"OG002","value":"29.5","lowerLimit":"13.8","upperLimit":"63.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"14.2","lowerLimit":"4.5","upperLimit":"44.7"},{"groupId":"OG001","value":"8.5","lowerLimit":"3.5","upperLimit":"20.6"},{"groupId":"OG002","value":"7.6","lowerLimit":"3.0","upperLimit":"19.8"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"30.7","lowerLimit":"10.7","upperLimit":"87.9"},{"groupId":"OG001","value":"22.0","lowerLimit":"7.6","upperLimit":"63.7"},{"groupId":"OG002","value":"6.2","lowerLimit":"2.5","upperLimit":"15.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"17.8","lowerLimit":"5.9","upperLimit":"53.4"},{"groupId":"OG001","value":"14.1","lowerLimit":"4.9","upperLimit":"40.3"},{"groupId":"OG002","value":"6.2","lowerLimit":"2.7","upperLimit":"14.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"32.1","lowerLimit":"12.3","upperLimit":"84.2"},{"groupId":"OG001","value":"26.1","lowerLimit":"10.2","upperLimit":"66.7"},{"groupId":"OG002","value":"7.0","lowerLimit":"3.2","upperLimit":"15.6"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 9 Months of Age in Africa - Infants Safety Cohort","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"EU/mL","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention administration) and Day 29, Day 113 and Day 281 (28 days after each study intervention administration)","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","lowerLimit":"6.4","upperLimit":"6.4"},{"groupId":"OG001","value":"6.9","lowerLimit":"5.8","upperLimit":"8.1"},{"groupId":"OG002","value":"6.4","lowerLimit":"6.4","upperLimit":"6.4"},{"groupId":"OG003","value":"6.6","lowerLimit":"6.2","upperLimit":"6.9"}]}]},{"title":"S sonnei Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"16.9","lowerLimit":"7.8","upperLimit":"36.6"},{"groupId":"OG001","value":"17.5","lowerLimit":"9.5","upperLimit":"32.4"},{"groupId":"OG002","value":"17.3","lowerLimit":"9.1","upperLimit":"33.0"},{"groupId":"OG003","value":"6.4","lowerLimit":"6.4","upperLimit":"6.4"}]}]},{"title":"S sonnei Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"27.2","lowerLimit":"12.6","upperLimit":"58.3"},{"groupId":"OG001","value":"32.7","lowerLimit":"16.1","upperLimit":"66.6"},{"groupId":"OG002","value":"23.3","lowerLimit":"11.1","upperLimit":"48.9"},{"groupId":"OG003","value":"6.4","lowerLimit":"6.4","upperLimit":"6.4"}]}]},{"title":"S sonnei Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"240.4","lowerLimit":"60.3","upperLimit":"958.3"},{"groupId":"OG001","value":"264.7","lowerLimit":"105.1","upperLimit":"666.9"},{"groupId":"OG002","value":"171.0","lowerLimit":"67.7","upperLimit":"431.6"},{"groupId":"OG003","value":"6.4","lowerLimit":"6.4","upperLimit":"6.4"}]}]},{"title":"S sonnei Ab IgG, Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"128.5","lowerLimit":"60.1","upperLimit":"274.9"},{"groupId":"OG001","value":"99.5","lowerLimit":"50.4","upperLimit":"196.3"},{"groupId":"OG002","value":"63.4","lowerLimit":"24.4","upperLimit":"165.1"},{"groupId":"OG003","value":"6.4","lowerLimit":"6.4","upperLimit":"6.4"}]}]},{"title":"S sonnei Ab IgG, Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"429.9","lowerLimit":"155.7","upperLimit":"1186.8"},{"groupId":"OG001","value":"275.8","lowerLimit":"90.1","upperLimit":"844.3"},{"groupId":"OG002","value":"185.2","lowerLimit":"111.2","upperLimit":"308.4"},{"groupId":"OG003","value":"6.4","lowerLimit":"6.4","upperLimit":"6.4"}]}]},{"title":"S flexneri 1b Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6.0","lowerLimit":"2.5","upperLimit":"14.8"},{"groupId":"OG001","value":"6.4","lowerLimit":"3.9","upperLimit":"10.6"},{"groupId":"OG002","value":"4.2","lowerLimit":"2.4","upperLimit":"7.4"},{"groupId":"OG003","value":"5.9","lowerLimit":"4.1","upperLimit":"8.5"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"24.2","lowerLimit":"8.2","upperLimit":"71.2"},{"groupId":"OG001","value":"18.5","lowerLimit":"10.6","upperLimit":"32.3"},{"groupId":"OG002","value":"7.0","lowerLimit":"3.1","upperLimit":"16.0"},{"groupId":"OG003","value":"6.3","lowerLimit":"4.6","upperLimit":"8.6"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"16.3","lowerLimit":"6.7","upperLimit":"40.0"},{"groupId":"OG001","value":"9.4","lowerLimit":"4.9","upperLimit":"17.8"},{"groupId":"OG002","value":"6.3","lowerLimit":"3.1","upperLimit":"12.7"},{"groupId":"OG003","value":"7.4","lowerLimit":"5.0","upperLimit":"10.9"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"30.5","lowerLimit":"8.6","upperLimit":"108.0"},{"groupId":"OG001","value":"18.2","lowerLimit":"12.1","upperLimit":"27.5"},{"groupId":"OG002","value":"14.2","lowerLimit":"5.0","upperLimit":"40.2"},{"groupId":"OG003","value":"7.4","lowerLimit":"5.0","upperLimit":"10.9"}]}]},{"title":"S flexneri 1b Ab IgG, Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9.0","lowerLimit":"3.5","upperLimit":"23.2"},{"groupId":"OG001","value":"7.2","lowerLimit":"3.2","upperLimit":"16.1"},{"groupId":"OG002","value":"8.9","lowerLimit":"4.5","upperLimit":"17.3"},{"groupId":"OG003","value":"7.4","lowerLimit":"5.0","upperLimit":"10.9"}]}]},{"title":"S flexneri 1b Ab IgG, Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23.3","lowerLimit":"9.5","upperLimit":"57.0"},{"groupId":"OG001","value":"20.4","lowerLimit":"8.1","upperLimit":"51.2"},{"groupId":"OG002","value":"29.4","lowerLimit":"15.3","upperLimit":"56.6"},{"groupId":"OG003","value":"8.0","lowerLimit":"5.3","upperLimit":"12.0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","lowerLimit":"1.5","upperLimit":"9.0"},{"groupId":"OG001","value":"4.4","lowerLimit":"2.3","upperLimit":"8.3"},{"groupId":"OG002","value":"3.9","lowerLimit":"1.8","upperLimit":"8.4"},{"groupId":"OG003","value":"4.1","lowerLimit":"2.2","upperLimit":"7.4"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"34.6","lowerLimit":"11.0","upperLimit":"109.1"},{"groupId":"OG001","value":"40.5","lowerLimit":"16.3","upperLimit":"100.6"},{"groupId":"OG002","value":"17.1","lowerLimit":"6.0","upperLimit":"49.0"},{"groupId":"OG003","value":"4.6","lowerLimit":"2.5","upperLimit":"8.4"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"29.6","lowerLimit":"11.5","upperLimit":"76.6"},{"groupId":"OG001","value":"16.4","lowerLimit":"7.4","upperLimit":"36.3"},{"groupId":"OG002","value":"9.7","lowerLimit":"3.8","upperLimit":"24.7"},{"groupId":"OG003","value":"5.8","lowerLimit":"3.2","upperLimit":"10.6"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"81.6","lowerLimit":"38.9","upperLimit":"171.1"},{"groupId":"OG001","value":"77.4","lowerLimit":"31.1","upperLimit":"192.5"},{"groupId":"OG002","value":"65.5","lowerLimit":"33.0","upperLimit":"130.0"},{"groupId":"OG003","value":"7.2","lowerLimit":"3.6","upperLimit":"14.2"}]}]},{"title":"S flexneri 2a Ab IgG, Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9.9","lowerLimit":"2.5","upperLimit":"38.8"},{"groupId":"OG001","value":"11.2","lowerLimit":"2.7","upperLimit":"47.6"},{"groupId":"OG002","value":"14.4","lowerLimit":"5.2","upperLimit":"40.1"},{"groupId":"OG003","value":"7.7","lowerLimit":"3.9","upperLimit":"15.2"}]}]},{"title":"S flexneri 2a Ab IgG, Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"135.0","lowerLimit":"81.6","upperLimit":"223.1"},{"groupId":"OG001","value":"72.5","lowerLimit":"24.6","upperLimit":"213.7"},{"groupId":"OG002","value":"110.7","lowerLimit":"60.4","upperLimit":"203.0"},{"groupId":"OG003","value":"8.2","lowerLimit":"4.4","upperLimit":"15.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","lowerLimit":"1.3","upperLimit":"5.6"},{"groupId":"OG001","value":"5.1","lowerLimit":"2.7","upperLimit":"9.7"},{"groupId":"OG002","value":"2.6","lowerLimit":"1.4","upperLimit":"4.7"},{"groupId":"OG003","value":"3.3","lowerLimit":"2.2","upperLimit":"5.0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9.6","lowerLimit":"3.4","upperLimit":"26.9"},{"groupId":"OG001","value":"8.9","lowerLimit":"3.1","upperLimit":"25.2"},{"groupId":"OG002","value":"3.5","lowerLimit":"1.7","upperLimit":"7.3"},{"groupId":"OG003","value":"3.4","lowerLimit":"2.2","upperLimit":"5.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5.1","lowerLimit":"2.2","upperLimit":"12.2"},{"groupId":"OG001","value":"6.0","lowerLimit":"2.4","upperLimit":"15.1"},{"groupId":"OG002","value":"2.1","lowerLimit":"1.1","upperLimit":"4.2"},{"groupId":"OG003","value":"4.0","lowerLimit":"2.5","upperLimit":"6.4"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12.5","lowerLimit":"4.0","upperLimit":"38.4"},{"groupId":"OG001","value":"7.9","lowerLimit":"2.5","upperLimit":"25.1"},{"groupId":"OG002","value":"4.5","lowerLimit":"2.3","upperLimit":"8.8"},{"groupId":"OG003","value":"3.8","lowerLimit":"2.4","upperLimit":"5.8"}]}]},{"title":"S flexneri 3a Ab IgG, Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6.8","lowerLimit":"2.4","upperLimit":"19.2"},{"groupId":"OG001","value":"8.5","lowerLimit":"2.0","upperLimit":"35.6"},{"groupId":"OG002","value":"3.2","lowerLimit":"1.6","upperLimit":"6.5"},{"groupId":"OG003","value":"4.5","lowerLimit":"2.8","upperLimit":"7.0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23.0","lowerLimit":"7.0","upperLimit":"75.8"},{"groupId":"OG001","value":"20.4","lowerLimit":"5.2","upperLimit":"79.7"},{"groupId":"OG002","value":"13.2","lowerLimit":"3.5","upperLimit":"49.8"},{"groupId":"OG003","value":"4.9","lowerLimit":"3.1","upperLimit":"7.9"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Anti-serotype Specific Shigella LPS/OAg Serum IgG GMCs in Participants 9 Months of Age in Africa - Dose-finding Cohort","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"EU/mL","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention administration) and Day 29, Day 113 and Day 281 (28 days after each study intervention administration)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10.9","lowerLimit":"8.9","upperLimit":"13.2"},{"groupId":"OG001","value":"9.5","lowerLimit":"8.1","upperLimit":"11.0"},{"groupId":"OG002","value":"10.7","lowerLimit":"8.7","upperLimit":"13.3"},{"groupId":"OG003","value":"9.8","lowerLimit":"8.2","upperLimit":"11.6"}]}]},{"title":"S sonnei Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"36.0","lowerLimit":"27.4","upperLimit":"47.4"},{"groupId":"OG001","value":"41.9","lowerLimit":"33.6","upperLimit":"52.4"},{"groupId":"OG002","value":"38.5","lowerLimit":"29.0","upperLimit":"51.3"},{"groupId":"OG003","value":"9.5","lowerLimit":"8.1","upperLimit":"11.1"}]}]},{"title":"S sonnei Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"41.7","lowerLimit":"32.3","upperLimit":"53.9"},{"groupId":"OG001","value":"46.7","lowerLimit":"36.8","upperLimit":"59.2"},{"groupId":"OG002","value":"41.1","lowerLimit":"33.5","upperLimit":"50.6"},{"groupId":"OG003","value":"8.2","lowerLimit":"6.9","upperLimit":"9.7"}]}]},{"title":"S sonnei Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"313.6","lowerLimit":"224.5","upperLimit":"438.1"},{"groupId":"OG001","value":"353.4","lowerLimit":"244.7","upperLimit":"510.4"},{"groupId":"OG002","value":"328.7","lowerLimit":"235.4","upperLimit":"459.1"},{"groupId":"OG003","value":"9.0","lowerLimit":"7.2","upperLimit":"11.3"}]}]},{"title":"S sonnei Ab IgG, Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"162.1","lowerLimit":"128.9","upperLimit":"203.8"},{"groupId":"OG001","value":"195.3","lowerLimit":"154.9","upperLimit":"246.2"},{"groupId":"OG002","value":"219.0","lowerLimit":"164.3","upperLimit":"291.8"},{"groupId":"OG003","value":"16.9","lowerLimit":"12.5","upperLimit":"22.8"}]}]},{"title":"S sonnei Ab IgG, Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"446.3","lowerLimit":"342.1","upperLimit":"582.3"},{"groupId":"OG001","value":"535.1","lowerLimit":"416.2","upperLimit":"688.0"},{"groupId":"OG002","value":"603.8","lowerLimit":"461.4","upperLimit":"790.2"},{"groupId":"OG003","value":"18.6","lowerLimit":"13.7","upperLimit":"25.2"}]}]},{"title":"S flexneri 1b Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11.4","lowerLimit":"8.5","upperLimit":"15.4"},{"groupId":"OG001","value":"11.8","lowerLimit":"8.7","upperLimit":"15.9"},{"groupId":"OG002","value":"12.6","lowerLimit":"9.1","upperLimit":"17.3"},{"groupId":"OG003","value":"13.4","lowerLimit":"9.9","upperLimit":"18.0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"32.9","lowerLimit":"23.7","upperLimit":"45.6"},{"groupId":"OG001","value":"47.5","lowerLimit":"34.8","upperLimit":"64.9"},{"groupId":"OG002","value":"36.8","lowerLimit":"26.5","upperLimit":"51.0"},{"groupId":"OG003","value":"13.4","lowerLimit":"10.0","upperLimit":"18.0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13.0","lowerLimit":"9.9","upperLimit":"17.0"},{"groupId":"OG001","value":"11.1","lowerLimit":"8.5","upperLimit":"14.4"},{"groupId":"OG002","value":"9.6","lowerLimit":"7.5","upperLimit":"12.3"},{"groupId":"OG003","value":"8.1","lowerLimit":"6.2","upperLimit":"10.7"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25.4","lowerLimit":"18.5","upperLimit":"34.8"},{"groupId":"OG001","value":"21.2","lowerLimit":"17.4","upperLimit":"25.8"},{"groupId":"OG002","value":"20.6","lowerLimit":"16.4","upperLimit":"25.8"},{"groupId":"OG003","value":"7.4","lowerLimit":"5.7","upperLimit":"9.5"}]}]},{"title":"S flexneri 1b Ab IgG, Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15.7","lowerLimit":"11.6","upperLimit":"21.3"},{"groupId":"OG001","value":"9.3","lowerLimit":"7.4","upperLimit":"11.7"},{"groupId":"OG002","value":"10.3","lowerLimit":"7.8","upperLimit":"13.5"},{"groupId":"OG003","value":"16.9","lowerLimit":"11.7","upperLimit":"24.2"}]}]},{"title":"S flexneri 1b Ab IgG, Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"57.3","lowerLimit":"43.2","upperLimit":"76.0"},{"groupId":"OG001","value":"34.4","lowerLimit":"26.6","upperLimit":"44.3"},{"groupId":"OG002","value":"36.7","lowerLimit":"28.1","upperLimit":"47.9"},{"groupId":"OG003","value":"16.6","lowerLimit":"11.5","upperLimit":"23.9"}]}]},{"title":"S flexneri 2a Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6.1","lowerLimit":"4.6","upperLimit":"8.2"},{"groupId":"OG001","value":"5.2","lowerLimit":"4.0","upperLimit":"6.6"},{"groupId":"OG002","value":"6.2","lowerLimit":"4.7","upperLimit":"8.2"},{"groupId":"OG003","value":"5.7","lowerLimit":"4.4","upperLimit":"7.5"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"51.6","lowerLimit":"38.1","upperLimit":"69.9"},{"groupId":"OG001","value":"58.2","lowerLimit":"42.6","upperLimit":"79.5"},{"groupId":"OG002","value":"59.4","lowerLimit":"42.2","upperLimit":"83.7"},{"groupId":"OG003","value":"6.2","lowerLimit":"4.7","upperLimit":"8.2"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"20.0","lowerLimit":"14.0","upperLimit":"28.6"},{"groupId":"OG001","value":"12.7","lowerLimit":"9.2","upperLimit":"17.7"},{"groupId":"OG002","value":"14.4","lowerLimit":"10.1","upperLimit":"20.6"},{"groupId":"OG003","value":"4.7","lowerLimit":"3.2","upperLimit":"6.7"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"95.4","lowerLimit":"72.4","upperLimit":"125.5"},{"groupId":"OG001","value":"69.9","lowerLimit":"52.2","upperLimit":"93.7"},{"groupId":"OG002","value":"84.4","lowerLimit":"62.4","upperLimit":"114.2"},{"groupId":"OG003","value":"4.5","lowerLimit":"3.2","upperLimit":"6.4"}]}]},{"title":"S flexneri 2a Ab IgG, Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"27.5","lowerLimit":"19.9","upperLimit":"38.1"},{"groupId":"OG001","value":"19.5","lowerLimit":"15.3","upperLimit":"25.0"},{"groupId":"OG002","value":"23.2","lowerLimit":"18.0","upperLimit":"30.0"},{"groupId":"OG003","value":"11.8","lowerLimit":"8.2","upperLimit":"17.1"}]}]},{"title":"S flexneri 2a Ab IgG, Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"189.2","lowerLimit":"139.2","upperLimit":"257.2"},{"groupId":"OG001","value":"142.3","lowerLimit":"112.6","upperLimit":"179.7"},{"groupId":"OG002","value":"177.9","lowerLimit":"134.7","upperLimit":"234.9"},{"groupId":"OG003","value":"12.1","lowerLimit":"8.3","upperLimit":"17.4"}]}]},{"title":"S flexneri 3a Ab IgG, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8.1","lowerLimit":"5.3","upperLimit":"12.5"},{"groupId":"OG001","value":"5.4","lowerLimit":"3.7","upperLimit":"7.9"},{"groupId":"OG002","value":"6.3","lowerLimit":"4.1","upperLimit":"9.6"},{"groupId":"OG003","value":"10.2","lowerLimit":"6.6","upperLimit":"15.8"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22.4","lowerLimit":"15.2","upperLimit":"33.0"},{"groupId":"OG001","value":"19.1","lowerLimit":"12.8","upperLimit":"28.5"},{"groupId":"OG002","value":"14.8","lowerLimit":"9.7","upperLimit":"22.6"},{"groupId":"OG003","value":"10.0","lowerLimit":"6.3","upperLimit":"15.8"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11.1","lowerLimit":"7.3","upperLimit":"16.6"},{"groupId":"OG001","value":"11.4","lowerLimit":"7.7","upperLimit":"16.8"},{"groupId":"OG002","value":"6.6","lowerLimit":"4.5","upperLimit":"9.8"},{"groupId":"OG003","value":"8.5","lowerLimit":"5.5","upperLimit":"13.2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25.7","lowerLimit":"17.3","upperLimit":"38.3"},{"groupId":"OG001","value":"18.4","lowerLimit":"12.2","upperLimit":"27.7"},{"groupId":"OG002","value":"16.0","lowerLimit":"11.2","upperLimit":"22.9"},{"groupId":"OG003","value":"7.7","lowerLimit":"5.2","upperLimit":"11.5"}]}]},{"title":"S flexneri 3a Ab IgG, Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13.5","lowerLimit":"9.8","upperLimit":"18.7"},{"groupId":"OG001","value":"8.8","lowerLimit":"6.6","upperLimit":"11.8"},{"groupId":"OG002","value":"9.6","lowerLimit":"6.9","upperLimit":"13.2"},{"groupId":"OG003","value":"10.7","lowerLimit":"7.4","upperLimit":"15.5"}]}]},{"title":"S flexneri 3a Ab IgG, Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"45.7","lowerLimit":"34.0","upperLimit":"61.5"},{"groupId":"OG001","value":"28.1","lowerLimit":"21.1","upperLimit":"37.4"},{"groupId":"OG002","value":"36.3","lowerLimit":"27.0","upperLimit":"48.8"},{"groupId":"OG003","value":"10.9","lowerLimit":"7.4","upperLimit":"16.1"}]}]}]},{"type":"SECONDARY","title":"Stage 1: Number of Participants 18 to 50 Years of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/OAg","populationDescription":"The analysis was performed on the PPS for Stage 1 Adults. As the participants in Stage 1 Adults: Placebo Group received the second placebo intervention at Day 85 or at Day 169, the analysis being performed on the pooled participants as per the SAP, no differentiation was made by timepoint of administration for the second dose for this group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1 and Day 85/Day 169 (before each study intervention); at Day 15 (14 days after the first study intervention); at Day 29 and Day 113/Day 197 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"5"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"4"}]}]},{"title":"Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"4"}]}]},{"title":"Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17"}]}]},{"title":"Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"14"}]}]},{"title":"Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"3"}]}]},{"title":"Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"21"}]}]},{"title":"Day 197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"22"}]}]},{"title":"Day 113/197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"3"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 18 to 50 Years of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/OAg","populationDescription":"The analysis was performed on the PPS for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"title":"Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"}]}]},{"title":"Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"5"}]}]},{"title":"Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"6"}]}]},{"title":"Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"5"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 24 to 59 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/OAg","populationDescription":"The analysis was performed on the PPS for Stage 2 Children.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"title":"Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"}]}]},{"title":"Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"2"}]}]},{"title":"Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"3"}]}]},{"title":"Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 9 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/Oag - Safety Cohort","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention) and Day 29, Day 113 and Day 281 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 9 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:800 Titer Against S. Sonnei LPS/Oag - Dose-finding Cohort","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention) and Day 29, Day 113 and Day 281 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"1"}]}]},{"title":"Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"51"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"57"},{"groupId":"OG003","value":"2"}]}]},{"title":"Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"48"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"8"}]}]},{"title":"Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"67"},{"groupId":"OG003","value":"8"}]}]}]},{"type":"SECONDARY","title":"Stage 1: Number of Participants 18 to 50 Years of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg","populationDescription":"The analysis was performed on the PPS for Stage 1 Adults. As the participants in Stage 1 Adults: Placebo Group received the second placebo intervention at Day 85 or at Day 169, the analysis being performed on the pooled participants as per the SAP, no differentiation was made by timepoint of administration for the second dose for this group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1 and Day 85/Day 169 (before each study intervention); at Day 15 (14 days after the first study intervention); at Day 29 and Day 113/Day 197 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"34"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"2"}]}]},{"title":"Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"2"}]}]},{"title":"Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"}]}]},{"title":"Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"9"}]}]},{"title":"Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"2"}]}]},{"title":"Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}]},{"title":"Day 197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"10"}]}]},{"title":"Day 113/197","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"2"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 18 to 50 Years of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg","populationDescription":"The analysis was performed on the PPS for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"title":"Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"}]}]},{"title":"Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"3"}]}]},{"title":"Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"3"}]}]},{"title":"Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"2"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 24 to 59 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg","populationDescription":"The analysis was performed on the PPS for Stage 2 Children.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1 and Day 85 (before each study intervention) and Day 29 and Day 113 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"title":"Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Day 29","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"0"}]}]},{"title":"Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"1"}]}]},{"title":"Day 113","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"3"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 9 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg - Safety Cohort","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention) and Day 29, Day 113 and Day 281 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 9 Months of Age Achieving a GVGH ELISA Level Equivalent to ≥1:1600 Titer Against S. Sonnei LPS/OAg - Dose-finding Cohort","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 1, Day 85 and Day 253 (before each study intervention) and Day 29, Day 113 and Day 281 (28 days after each study intervention)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 29","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Day 113","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"36"},{"groupId":"OG002","value":"36"},{"groupId":"OG003","value":"1"}]}]},{"title":"Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"2"}]}]},{"title":"Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"47"},{"groupId":"OG003","value":"2"}]}]}]},{"type":"SECONDARY","title":"Stage 1: Number of Participants 18 to 50 Years of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA","populationDescription":"The analysis was performed on the PPS for Stage 1 Adults. As the participants in Stage 1 Adults: Placebo Group received the second placebo intervention at Day 85 or at Day 169, the analysis being performed on the pooled participants as per the SAP, no differentiation was made by timepoint of administration for the second dose for this group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 15 (14 days after the first study intervention) and at Day 29 and Day 113/Day 197 (28 days after each study intervention) compared to baseline (Day 1 and Day 85/Day 169)","groups":[{"id":"OG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 15 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"27"},{"groupId":"OG002","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"}]}]},{"title":"S sonnei Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"}]}]},{"title":"S sonnei Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 169 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"21"}]}]},{"title":"S sonnei Ab IgG, Day 85/169 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 197 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"26"}]}]},{"title":"S sonnei Ab IgG, Day 197 compared to Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"4"}]}]},{"title":"S sonnei Ab IgG, Day 113/197 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 113/197 compared to Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 15 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]},{"title":"S flexneri 1b Ab IgG, Day 169 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"5"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85/169 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 197 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"10"}]}]},{"title":"S flexneri 1b Ab IgG, Day 197 compared to Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"1"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113/197 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113/197 compared to Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 15 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"27"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]},{"title":"S flexneri 2a Ab IgG, Day 169 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"31"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85/169 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 197 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"32"}]}]},{"title":"S flexneri 2a Ab IgG, Day 197 compared to Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113/197 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113/197 compared to Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"1"}]}]},{"title":"S flexneri 3a Ab IgG, Day 15 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 169 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"4"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85/169 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}]},{"title":"S flexneri 3a Ab IgG, Day 197 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"9"}]}]},{"title":"S flexneri 3a Ab IgG, Day 197 compared to Day 169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"1"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113/197 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113/197 compared to Day 85/169","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG002","value":"0"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 18 to 50 Years of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA","populationDescription":"The analysis was performed on the PPS for Stage 2 Adults.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 29 and Day 113 (28 days after each study intervention) compared to baseline (Day 1 and Day 85)","groups":[{"id":"OG000","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 29 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 85 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 113 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"0"}]}]},{"title":"S Sonnei Ab IgG, Day 113 compared to Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 24 to 59 Months of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA","populationDescription":"The analysis was performed on the PPS for Stage 2 Children.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 29 and Day 113 (28 days after each study intervention) compared to baseline (Day 1 and Day 85)","groups":[{"id":"OG000","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"20"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 29 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"1"}]}]},{"title":"S sonnei Ab IgG, Day 85 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"}]}]},{"title":"S sonnei Ab IgG, Day 113 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"}]}]},{"title":"S sonnei Ab IgG, Day 113 compared to Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"1"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"1"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 1","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 85","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 9 Months of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA - Safety Cohort","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, safety cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 29, Day 113 and Day 281 (28 days after each study intervention) compared to baseline (Day 1, Day 85 and Day 253)","groups":[{"id":"OG000","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 253 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 281 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 281 compared to Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"S flexneri 1b Ab IgG, Day 253 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"5"}]}]},{"title":"S flexneri 1b Ab IgG, Day 281 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 1b Ab IgG, Day 281 compared to Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"6"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 2a Ab IgG, Day 253 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"}]}]},{"title":"S flexneri 2a Ab IgG, Day 281 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"7"}]}]},{"title":"S flexneri 2a Ab IgG, Day 281 compared to Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"S flexneri 3a Ab IgG, Day 253 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"27"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 3a Ab IgG, Day 281 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"26"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 281 compared to Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 9 Months of Age Showing at Least a 4-fold Increase in Anti-serotype Specific Shigella LPS/OAg Serum IgG Concentrations, as Measured by GVGH ELISA - Dose-finding Cohort","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At Day 29, Day 113 and Day 281 (28 days after each study intervention) compared to baseline (Day 1, Day 85 and Day 253)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"classes":[{"title":"S sonnei Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"20"},{"groupId":"OG003","value":"3"}]}]},{"title":"S sonnei Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"64"},{"groupId":"OG003","value":"2"}]}]},{"title":"S sonnei Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"15"},{"groupId":"OG003","value":"0"}]}]},{"title":"S sonnei Ab IgG, Day 253 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"60"},{"groupId":"OG002","value":"58"},{"groupId":"OG003","value":"11"}]}]},{"title":"S sonnei Ab IgG, Day 281 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"62"},{"groupId":"OG002","value":"69"},{"groupId":"OG003","value":"12"}]}]},{"title":"S sonnei Ab IgG, Day 281 compared to Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"1"}]}]},{"title":"S flexneri 1b Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 1b Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"1"}]}]},{"title":"S flexneri 1b Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"}]}]},{"title":"S flexneri 1b Ab IgG, Day 253 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"12"}]}]},{"title":"S flexneri 1b Ab IgG, Day 281 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"13"}]}]},{"title":"S flexneri 1b Ab IgG, Day 281 compared to Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"13"},{"groupId":"OG003","value":"1"}]}]},{"title":"S flexneri 2a Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 2a Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"8"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"58"},{"groupId":"OG003","value":"7"}]}]},{"title":"S flexneri 2a Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"36"},{"groupId":"OG002","value":"42"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 2a Ab IgG, Day 253 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"27"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"18"}]}]},{"title":"S flexneri 2a Ab IgG, Day 281 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"65"},{"groupId":"OG003","value":"16"}]}]},{"title":"S flexneri 2a Ab IgG, Day 281 compared to Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"48"},{"groupId":"OG002","value":"52"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 3a Ab IgG, Day 29 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"74"},{"groupId":"OG002","value":"78"},{"groupId":"OG003","value":"80"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"3"}]}]},{"title":"S flexneri 3a Ab IgG, Day 85 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"75"},{"groupId":"OG003","value":"74"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"10"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"70"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"73"},{"groupId":"OG003","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"9"}]}]},{"title":"S flexneri 3a Ab IgG, Day 113 compared to Day 85","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"2"}]}]},{"title":"S flexneri 3a Ab IgG, Day 253 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"72"},{"groupId":"OG003","value":"70"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"16"},{"groupId":"OG003","value":"18"}]}]},{"title":"S flexneri 3a Ab IgG, Day 281 compared to Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"36"},{"groupId":"OG002","value":"41"},{"groupId":"OG003","value":"17"}]}]},{"title":"S flexneri 3a Ab IgG, Day 281 compared to Day 253","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"2"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Anti-measles IgG Concentrations in Participants 9 Months of Age in the Dose-finding Cohort","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"mIU/mL","timeFrame":"At Day 1 (before first measles and rubella vaccine (MR-VAC)) and at Day 281 (28 days after the second MR-VAC administration)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26.2","lowerLimit":"23.8","upperLimit":"28.9"},{"groupId":"OG001","value":"25.4","lowerLimit":"24.6","upperLimit":"26.1"},{"groupId":"OG002","value":"25","lowerLimit":"25","upperLimit":"25"},{"groupId":"OG003","value":"26.2","lowerLimit":"24.5","upperLimit":"28.1"}]}]},{"title":"Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1204.4","lowerLimit":"1043.2","upperLimit":"1390.6"},{"groupId":"OG001","value":"1099.7","lowerLimit":"957.2","upperLimit":"1263.4"},{"groupId":"OG002","value":"1142.5","lowerLimit":"983","upperLimit":"1327.9"},{"groupId":"OG003","value":"971.4","lowerLimit":"793.2","upperLimit":"1189.7"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Anti-rubella IgG Concentrations in Participants 9 Months of Age in the Dose-finding Groups","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"mIU/mL","timeFrame":"At Day 1 (before first measles and rubella vaccine (MR-VAC)) and at Day 281 (28 days after the second MR-VAC administration)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"81"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"83"},{"groupId":"OG003","value":"82"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","lowerLimit":"1","upperLimit":"1.4"},{"groupId":"OG001","value":"1","lowerLimit":"1","upperLimit":"1"},{"groupId":"OG002","value":"1.1","lowerLimit":"1","upperLimit":"1.3"},{"groupId":"OG003","value":"1.1","lowerLimit":"1","upperLimit":"1.1"}]}]},{"title":"Day 281","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"138.2","lowerLimit":"124.7","upperLimit":"153.1"},{"groupId":"OG001","value":"110.3","lowerLimit":"99.6","upperLimit":"122.1"},{"groupId":"OG002","value":"116.4","lowerLimit":"105.1","upperLimit":"129"},{"groupId":"OG003","value":"107.1","lowerLimit":"89.9","upperLimit":"127.5"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 9 Months of Age in the Dose-finding Groups Achieving Anti-measles IgG Concentrations of ≥150 Milli International Units Per Milliliter (mIU/mL) and ≥200 mIU/mL","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Day 281 (28 days after the second MR-VAC administration)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"classes":[{"title":">= 150 mIU/mL, Day 281","categories":[{"measurements":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"68"}]}]},{"title":">= 200 mIU/mL, Day 281","categories":[{"measurements":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"67"}]}]}]},{"type":"SECONDARY","title":"Stage 2: Number of Participants 9 Months of Age in the Dose-finding Groups Achieving Anti-rubella IgG Concentrations of ≥4 mIU/mL and ≥10 mIU/mL","populationDescription":"The analysis was performed on the PPS for Stage 2 Infants, dose-finding cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Day 281 (28 days after the second MR-VAC administration)","groups":[{"id":"OG000","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG001","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG002","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a)."},{"id":"OG003","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"69"}]}],"classes":[{"title":">= 4 IU/mL Day 281","categories":[{"measurements":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"68"}]}]},{"title":">= 10 IU/mL Day 281","categories":[{"measurements":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"68"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"Solicited AEs were collected within 7 days and unsolicited AEs within 28 days after any intervention (administered on Day (D) 1 and D85 for Stage 1 adults, Stage 2 adults and children and D1, D85 and D253 for Stage 2 infants). SAEs and all-cause mortality: from Day (D) 1 to D113/D197 for stage 1, from D1 to D113 for Stage 2 adults & children, from D1 to D281 for Stage 2 infants.","eventGroups":[{"id":"EG000","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 1","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 micrograms (µg) O-antigen (OAg) of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":34,"seriousNumAffected":0,"seriousNumAtRisk":34,"otherNumAffected":33,"otherNumAtRisk":34},{"id":"EG001","title":"Stage 1 Adults: altSonflex1-2-3 High Dose Group 2","description":"European participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 169. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":34,"seriousNumAffected":1,"seriousNumAtRisk":34,"otherNumAffected":33,"otherNumAtRisk":34},{"id":"EG002","title":"Stage 1 Adults: Placebo Group","description":"European participants 18-50 years of age were randomized to receive 1 dose of Placebo on Day 1 and on Day 85 or 169. All participants in Step 1 that received placebo were pooled, as pre-specified in Statistical Analysis Plan.","deathsNumAffected":0,"deathsNumAtRisk":34,"seriousNumAffected":0,"seriousNumAtRisk":34,"otherNumAffected":32,"otherNumAtRisk":34},{"id":"EG003","title":"Stage 2 Adults: altSonflex1-2-3 High Dose","description":"African participants 18-50 years of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained of 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":7,"otherNumAtRisk":10},{"id":"EG004","title":"Stage 2 Adults: Control","description":"African participants 18-50 years of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of BOOSTRIX as comparator Day 85.","deathsNumAffected":0,"deathsNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":5,"otherNumAtRisk":10},{"id":"EG005","title":"Stage 2 Children: altSonflex1-2-3 Medium Dose","description":"African participants 24-59 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1 and Day 85. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":9,"otherNumAtRisk":10},{"id":"EG006","title":"Stage 2 Children: altSonflex1-2-3 High Dose","description":"African participants 24-59 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1 and Day 85. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":5,"otherNumAtRisk":10},{"id":"EG007","title":"Stage 2 Children: Control","description":"African participants 24-59 months of age were randomized to receive 1 dose of MENVEO as comparator on Day 1 and 1 dose of TYPHIM VI as comparator on Day 85.","deathsNumAffected":0,"deathsNumAtRisk":20,"seriousNumAffected":0,"seriousNumAtRisk":20,"otherNumAffected":12,"otherNumAtRisk":20},{"id":"EG008","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. The measles-rubella vaccine (MR-VAC) was administered on Day 29 and Day 281. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":6,"otherNumAtRisk":10},{"id":"EG009","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":8,"otherNumAtRisk":10},{"id":"EG010","title":"Stage 2 Infants Safety Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was administered on Day 29 and Day 281. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":10,"otherNumAtRisk":10},{"id":"EG011","title":"Stage 2 Infants Safety Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was administered on Day 29 and Day 281.","deathsNumAffected":0,"deathsNumAtRisk":30,"seriousNumAffected":1,"seriousNumAtRisk":30,"otherNumAffected":26,"otherNumAtRisk":30},{"id":"EG012","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Low Dose","description":"African participants 9 months of age were randomized to receive a low dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Low dose of altSonflex1-2-3 contained 3.75 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":82,"seriousNumAffected":2,"seriousNumAtRisk":82,"otherNumAffected":77,"otherNumAtRisk":82},{"id":"EG013","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 Medium Dose","description":"African participants 9 months of age were randomized to receive a medium dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. Medium dose of altSonflex1-2-3 contained 7.5 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":1,"deathsNumAtRisk":81,"seriousNumAffected":1,"seriousNumAtRisk":81,"otherNumAffected":74,"otherNumAtRisk":81},{"id":"EG014","title":"Stage 2 Infants Dose-finding Cohort: altSonflex1-2-3 High Dose","description":"African participants 9 months of age were randomized to receive a high dose of altSonflex1-2-3 on Day 1, Day 85 and Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses. High dose of altSonflex1-2-3 contained 15 µg OAg of each Shigella serotype (S. sonnei, S. flexneri 1b, S. flexneri 2a, S. flexneri 3a).","deathsNumAffected":0,"deathsNumAtRisk":83,"seriousNumAffected":4,"seriousNumAtRisk":83,"otherNumAffected":80,"otherNumAtRisk":83},{"id":"EG015","title":"Stage 2 Infants Dose-finding Cohort: Control","description":"African participants 9 months of age were randomized to receive a dose of MENVEO as comparator on Day 1 and Day 85 and INFRANRIX HEXA as comparator on Day 253. MR-VAC was co-administered on Day 1 and Day 253. This cohort was created to identify the preferred dose among low, medium and high doses.","deathsNumAffected":0,"deathsNumAtRisk":82,"seriousNumAffected":1,"seriousNumAtRisk":82,"otherNumAffected":69,"otherNumAtRisk":82}],"seriousEvents":[{"term":"Faecaloma","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Oral candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":2,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Thermal burn","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Infantile spasms","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Iron deficiency anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Lymph node pain","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":9,"numAffected":8,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":7,"numAffected":6,"numAtRisk":83},{"groupId":"EG015","numEvents":3,"numAffected":3,"numAtRisk":82}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Thrombocytosis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Palpitations","organSystem":"Cardiac disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Hypoacusis","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Autoimmune hypothyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Conjunctivitis allergic","organSystem":"Eye disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Eye irritation","organSystem":"Eye disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Eye pruritus","organSystem":"Eye disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Lacrimation increased","organSystem":"Eye disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Abdominal distension","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Cheilitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":2,"numAffected":1,"numAtRisk":10},{"groupId":"EG011","numEvents":3,"numAffected":3,"numAtRisk":30},{"groupId":"EG012","numEvents":4,"numAffected":4,"numAtRisk":82},{"groupId":"EG013","numEvents":15,"numAffected":15,"numAtRisk":81},{"groupId":"EG014","numEvents":5,"numAffected":5,"numAtRisk":83},{"groupId":"EG015","numEvents":15,"numAffected":14,"numAtRisk":82}]},{"term":"Enteritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":2,"numAffected":2,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":2,"numAffected":2,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Faeces hard","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":2,"numAffected":2,"numAtRisk":82}]},{"term":"Flatulence","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":2,"numAffected":2,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Irritable bowel syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Mouth ulceration","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Mucous stools","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Toothache","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":2,"numAffected":2,"numAtRisk":81},{"groupId":"EG014","numEvents":3,"numAffected":3,"numAtRisk":83},{"groupId":"EG015","numEvents":5,"numAffected":4,"numAtRisk":82}]},{"term":"Administration site erythema","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":5,"numAtRisk":34},{"groupId":"EG001","numEvents":10,"numAffected":8,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":10},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG010","numEvents":9,"numAffected":6,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":33,"numAffected":20,"numAtRisk":82},{"groupId":"EG013","numEvents":28,"numAffected":21,"numAtRisk":81},{"groupId":"EG014","numEvents":43,"numAffected":32,"numAtRisk":83},{"groupId":"EG015","numEvents":21,"numAffected":14,"numAtRisk":82}]},{"term":"Administration site pain","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":54,"numAffected":33,"numAtRisk":34},{"groupId":"EG001","numEvents":64,"numAffected":33,"numAtRisk":34},{"groupId":"EG002","numEvents":24,"numAffected":20,"numAtRisk":34},{"groupId":"EG003","numEvents":9,"numAffected":7,"numAtRisk":10},{"groupId":"EG004","numEvents":5,"numAffected":4,"numAtRisk":10},{"groupId":"EG005","numEvents":13,"numAffected":7,"numAtRisk":10},{"groupId":"EG006","numEvents":4,"numAffected":3,"numAtRisk":10},{"groupId":"EG007","numEvents":6,"numAffected":3,"numAtRisk":20},{"groupId":"EG008","numEvents":6,"numAffected":4,"numAtRisk":10},{"groupId":"EG009","numEvents":10,"numAffected":5,"numAtRisk":10},{"groupId":"EG010","numEvents":20,"numAffected":7,"numAtRisk":10},{"groupId":"EG011","numEvents":12,"numAffected":7,"numAtRisk":30},{"groupId":"EG012","numEvents":101,"numAffected":49,"numAtRisk":82},{"groupId":"EG013","numEvents":117,"numAffected":57,"numAtRisk":81},{"groupId":"EG014","numEvents":127,"numAffected":58,"numAtRisk":83},{"groupId":"EG015","numEvents":60,"numAffected":35,"numAtRisk":82}]},{"term":"Administration site swelling","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":5,"numAtRisk":34},{"groupId":"EG001","numEvents":12,"numAffected":9,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":10},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG010","numEvents":11,"numAffected":5,"numAtRisk":10},{"groupId":"EG011","numEvents":6,"numAffected":5,"numAtRisk":30},{"groupId":"EG012","numEvents":55,"numAffected":30,"numAtRisk":82},{"groupId":"EG013","numEvents":53,"numAffected":32,"numAtRisk":81},{"groupId":"EG014","numEvents":60,"numAffected":34,"numAtRisk":83},{"groupId":"EG015","numEvents":25,"numAffected":20,"numAtRisk":82}]},{"term":"Application site hypersensitivity","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Axillary pain","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Chills","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Feeling hot","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Influenza like illness","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":34},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":34},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site discolouration","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site eczema","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site erythema","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site haematoma","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site induration","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site nodule","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site pain","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site rash","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site reaction","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Injection site warmth","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Peripheral swelling","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":20},{"groupId":"EG008","numEvents":2,"numAffected":1,"numAtRisk":10},{"groupId":"EG009","numEvents":3,"numAffected":3,"numAtRisk":10},{"groupId":"EG010","numEvents":6,"numAffected":5,"numAtRisk":10},{"groupId":"EG011","numEvents":10,"numAffected":9,"numAtRisk":30},{"groupId":"EG012","numEvents":48,"numAffected":38,"numAtRisk":82},{"groupId":"EG013","numEvents":35,"numAffected":28,"numAtRisk":81},{"groupId":"EG014","numEvents":44,"numAffected":37,"numAtRisk":83},{"groupId":"EG015","numEvents":22,"numAffected":18,"numAtRisk":82}]},{"term":"Swelling face","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Vaccination site pain","organSystem":"General disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Food allergy","organSystem":"Immune system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Abscess limb","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Amoebiasis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Amoebic dysentery","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Bacterial infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Body tinea","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"COVID-19","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":6,"numAffected":6,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Conjunctivitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":4,"numAffected":4,"numAtRisk":30},{"groupId":"EG012","numEvents":2,"numAffected":2,"numAtRisk":82},{"groupId":"EG013","numEvents":3,"numAffected":3,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Dermatitis infected","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":2,"numAffected":2,"numAtRisk":81},{"groupId":"EG014","numEvents":2,"numAffected":2,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Ear infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Furuncle","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":4,"numAffected":3,"numAtRisk":82},{"groupId":"EG013","numEvents":9,"numAffected":8,"numAtRisk":81},{"groupId":"EG014","numEvents":12,"numAffected":11,"numAtRisk":83},{"groupId":"EG015","numEvents":8,"numAffected":8,"numAtRisk":82}]},{"term":"Genital abscess","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Helminthic infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Infectious mononucleosis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Labyrinthitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Malaria","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":30},{"groupId":"EG012","numEvents":6,"numAffected":6,"numAtRisk":82},{"groupId":"EG013","numEvents":6,"numAffected":6,"numAtRisk":81},{"groupId":"EG014","numEvents":5,"numAffected":5,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Oral candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":3,"numAffected":3,"numAtRisk":82},{"groupId":"EG013","numEvents":2,"numAffected":2,"numAtRisk":81},{"groupId":"EG014","numEvents":6,"numAffected":5,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Otitis media","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Otitis media acute","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":2,"numAffected":2,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":2,"numAffected":2,"numAtRisk":82}]},{"term":"Plasmodium falciparum infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":2,"numAffected":2,"numAtRisk":82}]},{"term":"Rhinitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":20},{"groupId":"EG008","numEvents":3,"numAffected":2,"numAtRisk":10},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG010","numEvents":5,"numAffected":4,"numAtRisk":10},{"groupId":"EG011","numEvents":7,"numAffected":6,"numAtRisk":30},{"groupId":"EG012","numEvents":7,"numAffected":7,"numAtRisk":82},{"groupId":"EG013","numEvents":11,"numAffected":9,"numAtRisk":81},{"groupId":"EG014","numEvents":8,"numAffected":6,"numAtRisk":83},{"groupId":"EG015","numEvents":13,"numAffected":13,"numAtRisk":82}]},{"term":"Scabies","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Tonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":3,"numAffected":3,"numAtRisk":82},{"groupId":"EG013","numEvents":3,"numAffected":3,"numAtRisk":81},{"groupId":"EG014","numEvents":3,"numAffected":3,"numAtRisk":83},{"groupId":"EG015","numEvents":3,"numAffected":3,"numAtRisk":82}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":20},{"groupId":"EG008","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG009","numEvents":2,"numAffected":1,"numAtRisk":10},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":10},{"groupId":"EG011","numEvents":8,"numAffected":8,"numAtRisk":30},{"groupId":"EG012","numEvents":21,"numAffected":17,"numAtRisk":82},{"groupId":"EG013","numEvents":21,"numAffected":19,"numAtRisk":81},{"groupId":"EG014","numEvents":21,"numAffected":18,"numAtRisk":83},{"groupId":"EG015","numEvents":23,"numAffected":21,"numAtRisk":82}]},{"term":"Varicella","organSystem":"Infections and infestations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":2,"numAffected":2,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Arthropod bite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Bone contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Face injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Greenstick fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Hand fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Immunisation reaction","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Ligament sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Limb injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Muscle strain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Soft tissue injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Thermal burn","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":2,"numAffected":2,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Blood potassium increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Blood sodium increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Blood thyroid stimulating hormone increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Eosinophil count increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Haemoglobin decreased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":8,"numAffected":8,"numAtRisk":82},{"groupId":"EG013","numEvents":3,"numAffected":3,"numAtRisk":81},{"groupId":"EG014","numEvents":5,"numAffected":5,"numAtRisk":83},{"groupId":"EG015","numEvents":3,"numAffected":3,"numAtRisk":82}]},{"term":"Hepatic enzyme increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Lymphocyte count increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":3,"numAffected":3,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Neutrophil count decreased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":2,"numAffected":2,"numAtRisk":82}]},{"term":"Platelet count increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Respiratory rate increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"White blood cell count increased","organSystem":"Investigations","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":2,"numAffected":1,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":4,"numAffected":4,"numAtRisk":82},{"groupId":"EG013","numEvents":2,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Groin pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Limb discomfort","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Muscle tightness","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Myalgia intercostal","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":12,"numAtRisk":34},{"groupId":"EG001","numEvents":13,"numAffected":10,"numAtRisk":34},{"groupId":"EG002","numEvents":13,"numAffected":8,"numAtRisk":34},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":10},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Hypotonia","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Migraine","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Partial seizures","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Tension headache","organSystem":"Nervous system disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Dysmenorrhoea","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Vaginal discharge","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Allergic cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Bronchospasm","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":2,"numAffected":2,"numAtRisk":82}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":30},{"groupId":"EG012","numEvents":6,"numAffected":6,"numAtRisk":82},{"groupId":"EG013","numEvents":2,"numAffected":2,"numAtRisk":81},{"groupId":"EG014","numEvents":9,"numAffected":9,"numAtRisk":83},{"groupId":"EG015","numEvents":10,"numAffected":10,"numAtRisk":82}]},{"term":"Nasal congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Nasal discomfort","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Pulmonary congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Rhinitis allergic","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Rhinorrhoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":3,"numAffected":3,"numAtRisk":82},{"groupId":"EG013","numEvents":5,"numAffected":5,"numAtRisk":81},{"groupId":"EG014","numEvents":6,"numAffected":6,"numAtRisk":83},{"groupId":"EG015","numEvents":5,"numAffected":5,"numAtRisk":82}]},{"term":"Sneezing","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Upper-airway cough syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Blister","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Dermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":1,"numAffected":1,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Dermatitis allergic","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":2,"numAffected":2,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Eczema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":1,"numAffected":1,"numAtRisk":82}]},{"term":"Pruritus","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":2,"numAffected":2,"numAtRisk":82},{"groupId":"EG013","numEvents":3,"numAffected":3,"numAtRisk":81},{"groupId":"EG014","numEvents":5,"numAffected":5,"numAtRisk":83},{"groupId":"EG015","numEvents":4,"numAffected":3,"numAtRisk":82}]},{"term":"Rash pruritic","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":0,"numAffected":0,"numAtRisk":82},{"groupId":"EG013","numEvents":0,"numAffected":0,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]},{"term":"Urticaria","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"v28.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":34},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":20},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":10},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":30},{"groupId":"EG012","numEvents":1,"numAffected":1,"numAtRisk":82},{"groupId":"EG013","numEvents":1,"numAffected":1,"numAtRisk":81},{"groupId":"EG014","numEvents":0,"numAffected":0,"numAtRisk":83},{"groupId":"EG015","numEvents":0,"numAffected":0,"numAtRisk":82}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"GSK Response Center","organization":"GlaxoSmithKline","email":"GSKClinicalSupportHD@gsk.com","phone":"866-435-7343"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2023-10-31","uploadDate":"2025-12-22T03:06","filename":"Prot_000.pdf","size":2452332},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2024-03-19","uploadDate":"2025-12-22T03:06","filename":"SAP_001.pdf","size":1143702}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"conditionBrowseModule":{"meshes":[{"id":"D003967","term":"Diarrhea"},{"id":"D004405","term":"Dysentery, Bacillary"}],"ancestors":[{"id":"D012817","term":"Signs and Symptoms, Digestive"},{"id":"D012816","term":"Signs and Symptoms"},{"id":"D013568","term":"Pathological Conditions, Signs and Symptoms"},{"id":"D004756","term":"Enterobacteriaceae Infections"},{"id":"D016905","term":"Gram-Negative Bacterial Infections"},{"id":"D001424","term":"Bacterial Infections"},{"id":"D001423","term":"Bacterial Infections and Mycoses"},{"id":"D007239","term":"Infections"},{"id":"D004403","term":"Dysentery"},{"id":"D005759","term":"Gastroenteritis"},{"id":"D005767","term":"Gastrointestinal Diseases"},{"id":"D004066","term":"Digestive System Diseases"},{"id":"D007410","term":"Intestinal Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D022401","term":"Meningococcal Vaccines"},{"id":"C505143","term":"Boostrix"},{"id":"C541235","term":"diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine"},{"id":"C057664","term":"Vi polysaccharide vaccine, typhoid"}],"ancestors":[{"id":"D001428","term":"Bacterial Vaccines"},{"id":"D014612","term":"Vaccines"},{"id":"D001688","term":"Biological Products"},{"id":"D045424","term":"Complex Mixtures"}]}},"hasResults":true}